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SUMMARY 
For decades, scientists have thought that female mammals are born with a lifetime 
supply of oocytes in the ovary, irreversibly destined to decline after birth. However, in 
recent years a significant controversy with regard to the potential replenishing effects 
of cells from the bone marrow and blood on ovarian follicular renewal has been 
stirred up. Although these claims have been met with harsh skepticism, if they prove 
to be true, the current understanding of the female reproductive system must be 
revisited. Although these observations and allusions have been limited to the mouse 
system only, they have opened new discussions about the potential consequences of 
bone marrow transplantation and even blood donation to the replenishment of the 
female genital system in general. Still, these findings have not been replicated in other 
research laboratories so far and the proof that oogenesis can be renewed after birth 
from cells originating in the bone marrow is still lacking.  
In contrast to the ongoing controversy with regard to the possibility of ongoing 
renewal of oogenesis in the ovary and the possible existence of adult germ stem cells, 
the existence of somatic stem cells in the ovary has not been hypothesized for a long 
time.  
The first part of this study has been performed to confirm the presence of pluripotent 
or multipotent stem cell populations among granulosa cells collected from mature 
human ovarian follicles. This work includes attempts to promote the growth of GCs 
over prolonged time periods in vitro. Previous studies have demonstrated that this is 
not possible with culture media which contain FSH and androgens. We identify the 
  
specific markers for mesenchymal stem cells and mature GCs and differentiate 
luteinizing GCs into other cell types of the mesenchymal lineage. 
Graafian ovarian follicles consist of follicular fluid, one single mature oocyte and 
several hundred thousands of granulosa cells (GC). Until now, luteinizing GCs are 
considered to be terminally differentiated, destined to undergo death after ovulation. 
Present concepts of luteal function, endocrine regulation of early pregnancy and the 
recruitment of new ovarian follicles are all based on the cyclical renewal of the entire 
population of GC.  
The first part of this study has been performed to confirm the presence of pluripotent 
or multipotent stem cell populations among granulosa cells collected from mature 
human ovarian follicles. This work includes attempts to promote the growth of GCs 
over prolonged time periods in vitro. Previous studies have demonstrated that this is 
not possible with culture media which contain FSH and androgens. We identify the 
specific markers for mesenchymal stem cells and mature GCs and differentiate 
luteinizing GCs into other cell types of the mesenchymal lineage. 
In the second part we demonstrate a three-dimensional (3D) pellet culture system 
containing type I collagen, which together with LIF allowed not only the survival and 
growth of primary human GCs, but supported a significant subpopulation of GCs to 
maintain their phenotype and functionality for prolonged time periods. 
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ABBREVIATIONS 
 
3D – three dimensional  
APC - Allophycocyanin 
ART – assisted reproduction technology 
bFGF - basic fibroblast growth factor  
BM – bone marrow 
BMST – bone marrow stromal cells 
BMT – bone marrow transplantation 
BSP – bone sialoprotein 
cDNA – single strand DNA 
COC – cumulus oophorus oocyte complex 
COLL1 – Collagen 1 
COLL 2 – Collagen 2 
CT - chemotherapy 
DMEM – Dulbecco’s modified Eagle’s medium 
DMSO - dimethylsulphoxide 
DNA - Deoxyribonucleic acid 
E2 - estradiol 
ECM – extracellular matrix 
EGF - epidermal growth factor 
FACS – Fluorescence Activated Cell Sorter 
FITC – fluorescence isothiocyanate 
FCS – fetal calf serum 
FSH – follicle stimulation hormone 
FSHR – follicle stimulation hormone receptor 
GAG - glycosaminoglycan 
GAPDH - Glyceraldehyde 3-phosphate dehydrogenase 
GC – granulosa cells 
GFP – green fluorescent protein 
GSC – germline stem cells 
H&E - hematoxylin and eosin 
HCG – human chorionic gonadotropin 
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HGF - hepatocyte growth factor 
HLA-ABC - human leukocyte antigen class I 
HMG – human menopausal gonadotropin 
ICSI – intracytoplasmic sperm injection 
IGF-1 - Insulin-like growth factor 1 
IVF – in vitro fertilization  
IVM – in vitro maturation 
ITS-1 – Insulin, Transferrin, Selenium 
LH – luteinization hormone 
LHR – luteinization hormone receptor 
LIF – leukemia inhibiting factor 
LIFR – leukemia inhibiting factor receptor 
MSC – mesenchymal stem cells 
OC - osteocalcin 
OCT-4 – denominated POU5F1 
OP - osteopontin 
OSE – ovarian surface epithelium 
P4 - progesterone 
PCR – polymerase chain reaction 
PE - Phycoerythrin 
pI – propidium iodide 
POF – premature ovarian failure 
POU5F1 – POU domain, class 5 homebox 1 
PB – peripheral blood 
RNA - Ribonucleic acid 
SE – surface epithelium  
SOX-9 - sex determining region Y box 9 
TA – tunica albuginea 
TGF beta (TGF-β) - transforming growth factor beta 
VEGF - vascular endothelial growth factor 
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1 INTRODUCTION 
1.1 THE BASIC DOGMA OF REPRODUCTIVE BIOLOGY 
A central dogma of reproductive biology has been that females of most mammalian 
species have the capacity of producing a defined stock of oocytes during fetal 
development only, each oocyte being enclosed by somatic cells in globular structures 
referred to as ovarian follicles [Zuckerman, 1951; Zuckerman and Baker, 1977]. 
Despite repeated but short-lived criticisms [Pansky et al., 1953; Vermande-Van Eck, 
1956; Artem’eva, 1961] Zuckerman in 1951 settled the debate in favour of a 
quantified reserve of oocytes fixed at birth: “The basic biological doctrine that during 
the life of the individual there neither is nor can be any increase in the number of 
primary oocytes beyond those originally laid down when the ovary was formed” 
[Zuckerman, 1951]. 
In part through a finely tuned hormonal regulatory network, only a small fraction of 
the postnatal oocyte pool acquires the opportunity to become ovulated at some point 
during reproductive life. The fate of the vast majority of ovarian follicles enclosing 
the oocytes consists of atretic degeneration. The number of ovarian follicles steadily 
declines throughout adulthood to the point of exhaustion around age 50 culminating in 
menopause, which is defined as the last menstruation in a woman’s life time 
[Richardson et al., 1987]. 
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1.2 HISTORY OF THE BASIC DOGMA OF A PREDETERMINED NUMBER OF 
OVARIAN FOLLICLES AT BIRTH 
Today most scientists accept the dogma that all oogonia, i.e., the female germinal 
stem cells, become extinct early in life as they become transformed into oocytes. 
However, during the last 150 years and still now, neo-oogenesis in adult mammals is 
being discussed. Waldeyer in his publication ‘‘Eierstock und Ei’’ from 1870 
maintained the idea that no new formation of oocytes took place in adult mammals 
and birds, but that the oocytes arose in the ovarian surface epithelium, the so-called 
“germinal” epithelium, during a limited period early in life [Waldeyer, 1870]. His 
hypothesis was overturned by Kingery [Kingery, 1917], who claimed that all oocytes 
formed during fetal life degenerated and was replaced by oocytes arising in the adult 
ovarian “germinal” epithelium. Allen [Allen, 1923] supported this theory and stated 
that mitotic divisions in the “germinal” epithelium resulted in new oocytes. In 1921, 
Pearl and Schoppe cited a “basic biological doctrine that during the life of the 
individual there neither is nor can be any increase in the number of primary oocytes 
beyond those originally laid down when the ovary was formed” [Pearl et al., 1921]. 
This concept was solidified as a dogma in 1951 in a paper that critically evaluated, 
and effectively dispelled, any work contrary to the belief that mammalian females are 
endowed with a finite and non-renewing germ-cell reserve during the perinatal period. 
The discussion of neo-oogenesis in the adult mammalian ovary was almost ended by 
the studies of Zuckerman and his group [Zuckerman, 1951] and the Peters’ group 
[Peters et al., 1962]. Peters et al. showed that the premeiotic S phase leading to the 
formation of oocytes in the mouse only takes place during a limited prenatal period 
and that these oocytes remain in the adult ovary.  
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Accordingly, a central dogma of mammalian reproductive biology stipulates that 
females are born with a finite, non-renewing pool of germ cells (oocytes), all of which 
are arrested in meiosis I and are enclosed by somatic cells in structures referred to as 
follicles [Zuckerman, 1951; Borum, 1961; Franchi et al., 1962; Peters, 1970; 
McLaren, 1984; Anderson et al., 1992]. Oocyte numbers progressively decline 
throughout postnatal life [Faddy et al., 1976; Faddy et al., 1987; Faddy, 2000] through 
mechanisms involving apoptosis [Perez et al., 1999; Tilly, 2001] eventually leaving 
the ovaries barren of germ cells [Gosden et al., 1983]. In humans, exhaustion of the 
oocyte reserve occurs around the fifth decade of life, leading to menopause 
[Richardson et al., 1987]. The process that is believed to occur in female mammals 
with respect to germ-cell development differs from that of several invertebrate 
organisms, including Drosophila melanogaster, in which germinal stem cells 
maintain oocyte production in adult ovaries. [Lin, 1997; Spradling et al., 2001; Deng 
and Lin, 2001].  
It seems that few species have been shown to represent exceptions to the prevailing 
dogma. In pro-simian monkeys (e.g. lower primates), oocytes in transitory stages of 
the first meiotic prophase are confined to “germ cell nests” and are present both in 
juvenile and in adult ovaries, as first described in 1920 [Gerard, 1920], later 
confirmed by many others [Ioannou, 1967]. Also the armadillo’s ovary contains germ 
cells in meiosis but in this species they are confined to cord-like structures within the 
cortex [Enders, 1960]. 
From a phylogenetic viewpoint, it seems contradictory that mammalian females, 
including humans, would evolve a uniquely retrogressive reproductive mechanism, 
requiring preservation of their gametes from the fetal period for up to several decades. 
  
- 9 - 
Such long-lasting preservation could cause an accumulation of spontaneous or 
environmentally induced genetic alterations of oocytes in resting primary follicles 
[Bukovsky et al., 2005].  
Interestingly, the conclusion reached by Zuckerman [Zuckerman,1951] remained for 
the most part unchallenged for more than 50 years despite the fact that, as emphasized 
by Zuckerman himself later in his career [Zuckerman, 1971], his conclusion was not 
based on even one single experiment proving that female mammals are incapable of 
oogenesis during postnatal life. Instead, he arrived at this conclusion based solely on 
an absence of data he felt, that would be inconsistent with this idea [Tilly et al., 2007]. 
Although this dogma has persisted, newer studies provide some evidence that may 
challenge the validity of the prevailing belief, which represents one of the most basic 
underpinnings of reproductive biology. 
1.3 THE ONGOING CONTROVERSY SURROUNDING THE FINITE, NON-
RENEWABLE OVARIAN FOLLICLE POOL AFTER BIRTH 
Oogenesis has been demonstrated in cultured mouse embryonic stem cells [Hubner et 
al., 2003] and mitotically active germ cells have been reported in ovaries of adult pro-
simian primates [Ioannou et al., 1967] and mice [Johnson et al., 2004]. Mesenchymal 
cells in the ovarian tunica albuginea (TA) differentiate into surface epithelium, a 
source of germ cells entering blood vessels and contributing to follicular renewal in 
adult human females [Bukovsky et al., 1995; Bukovsky et al., 2004]. These reports all 
represent challenges to established dogma on the fetal origin of mammalian oocytes 
[Bazer et al., 2004; Gosden, 2004]. 
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Recently, Johnson and colleagues [Johnson et al., 2004] describe signs of preservation 
and proliferation of germline stem cells in postnatal mouse ovaries, thus opening the 
possibility of a postnatal contribution to the oocyte reserve. Another report based on 
the mouse model has recently suggested that, the number of primordial follicles per 
ovary do not decline between day 7 to day 100 after birth and that a significant 
depletion only occurred 200 days after birth [Kerr et al. 2006]. The authors propose 
that immature germ cells present in the adult may be able to generate de novo oocytes 
in a favourable environment. 
Johnson et al. [Johnson et al., 2004] based their conclusions of oocyte and follicular 
renewal from existing germline stem cells (GSC) in the postnatal mouse ovary on 
three types of observations: discordance in follicle loss versus follicle atresia in the 
neonatal period, detection of proliferating GSC with meiotic capacity and neo-
folliculogenesis in ovarian chimeric grafting experiments with adult mice.  
Based on the hypothesis of an extra-ovarian source of germ-line precursors able to 
migrate to the ovaries and contribute to new oocytes, these reports have led to the 
proposal that bone marrow or peripheral blood cell transplantation might provide 
novel treatments for premature menopause or chemotherapy-induced sterility 
[Johnson et al., 2005b]. However, interpretation of these results demand caution, as it 
was revealed that some cells associated with the ovulated oocytes and stained with 
markers of haematopoiesis, were in fact contaminated cells arising from blood 
circulation [Eggan et al., 2006]. 
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1.4 ARGUMENTS PUT FORWARD TO SUPPORT RENEWAL OF THE 
FOLLICLE-POOL AFTER BIRTH 
The hypothesis that oocyte and follicle renewal may still be ongoing in the postnatal 
mouse ovary was verified by several experimental approaches [Johnson et al., 2004].  
Mitotically active germ cells were suggested to be present in the ovaries of both 
young and adult mice, which, based on rates of oocyte atresia and clearance, are 
needed to continuously resupply the follicle pool [Johnson et al., 2004]. Histological 
analysis of young and adult mouse ovaries revealed the presence of large egg-shaped 
cells in the surface epithelial cell layer covering the ovary, similar to germ cells of 
fetal mouse ovaries [Crone et al., 1965; Morita et al., 1999]. These large ovoid cells 
were of a germline lineage as the presence of germ cells in various stages of mitosis 
was annotated. These data are considered by some scientists to build a strong case for 
germ-cell proliferation and follicle renewal in the postnatal mouse ovary. 
The renewal of the postnatal ovarian follicle pool was then verified using 
chemotherapy (CT): prepubertal female mice were treated with the germ-cell toxicant, 
busulphan, which is known to eliminate the primordial follicle reserve without 
inducing atresia. After treatment with CT, cells expressing the meiotic entry marker 
were demonstrated in young and adult mouse ovaries. Ovaries of females treated with 
CT possessed, however, less than 5 % of the normal primordial follicle pool. These 
data were put forward to support the concept that proliferative germ cells not only 
persist in the postnatal ovary but also are required to renew the follicle pool [Johnson 
et al., 2004]. 
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Wild-type ovaries were then grafted into transgenic female mice with ubiquitous 
expression of green fluorescent protein (GFP) [Hadjantonakis et al., 1998]. Grafted 
wild-type ovarian fragments penetrate into the GFP-positive ovarian tissue and 
follicle-enclosed wild-type germ cells gradually became indistinguishable from the 
GFP-positive germ cells that formed follicles. These data were proposed as a strong 
argument for the existence of proliferative germ cells that sustain oocyte and follicle 
production in the postnatal mammalian ovary [Johnson et al., 2004]. Considering 
results from past studies of mammalian stem-cell migration to their natural niches 
after introduction into a host [Nagano et al., 2003; Szilvassy et al., 2003; Torrente et 
al., 2003; Oh et al., 2003], the data presented above were interpreted such that germ-
line stem cells continue to exist in the postnatal mouse ovary. 
1.5 THE EXTRAGONADAL SOURCE OF GERMLINE STEM CELLS AFTER 
BIRTH 
After a further set of experiments Johnson and his collaborators [Johnson et al., 2005] 
claimed that adult mouse ovaries rapidly generate hundreds of oocytes within 24 
hours. The expression of germline markers in bone marrow (BM) was taken as an 
argument to suggest the presence of an extragonadal source of germ cells. 
Consequently, Johnson and colleagues began to claim that BM transplantation would 
be able to restore the production of oocytes in wild-type mice sterilized by CT, as well 
as in mice, which, due to genetic disease are incapable of producing oocytes. Based 
on gene expression analyses and bone marrow transplantation (BMT) experiments 
using CT-sterilized recipients, these authors presented the idea that a putative germ-
line stem cell reservoir supporting oogenesis in adult female mice resides in the BM. 
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The same authors also presented the idea that the peripheral blood (PB) contained an 
additional source of germ-line stem cells in female mice. After transfusion of 
peripheral blood (PB) harvested from transgenic females with germline-restricted 
green fluorescent protein (GFP) expression GFP-positive oocytes were demonstrated 
in the ovaries of CT-treated recipient females. These findings nurtured the hypothesis 
that putative germ cells in BM release progenitor cells into the peripheral circulation 
which then may migrate to the ovaries [Johnson et al., 2005a].   
1.6 THE OVARIAN SURFACE EPITHELIUM AS A SOURCE OF OVARIAN 
GERMLINE STEM CELLS 
In adult human females the ovarian surface epithelium (OSE) is thought to be a source 
of germ cells and new primary follicles are formed by assembly of oocytes with nests 
of primitive granulosa cells in the ovarian cortex [Bukovsky et al., 1995]. The latter 
authors investigated the possibility that the oocytes and granulosa cells may be able to 
differentiate in cultures derived from adult human ovaries, scraped from the surface of 
ovaries. OSE cells cultured in the presence of an estrogenic stimulus differentiated 
into cells presenting with the phenotype of oocytes. Such cells exhibited germinal 
vesicle breakdown, expulsion of the polar body, and proteins characteristics for 
secondary oocytes. These in vitro studies uphold in vivo observations that in adult 
human ovaries, the OSE is a potential source of both oocytes and granulosa cells 
[Bukovsky et al., 2005]. 
Regarding follicular renewal in adult human females, reports provide some evidence 
that the OSE could be a source of germ cells, and new primary follicles are formed by 
assembly of oocytes with nests of primitive granulosa cells in the ovarian cortex 
  
- 14 - 
[Bukovsky et al., 1995; Bukovsky et al., 2004]. Components for the new primary 
follicles, primitive granulosa and germ cells, are proposed to differentiate de novo 
from mesenchymal progenitor cells residing in the ovarian TA. During differentiation 
into OSE cells the mesenchymal progenitor cells line either the ovarian surface or 
invaginated epithelial crypts. Mesenchymal progenitor cells would first contribute to 
the development of epithelial cells similar to granulosa cells, and these cells 
subsequently form epithelial nests descending into the deeper ovarian cortex. These 
cells may be a source of germ cells, which assemble together with nests of primitive 
granulosa cells to form primary follicles [Bukovsky et al., 2005]. Oogenesis may 
follow later. 
The concept of cells from the OSE as the source of germline stem cells stands in 
contradiction to Johnson and colleagues [Johnson et al., 2005a], who favour cells 
from the BM and/or PB as the source of new germ cells that infiltrate the ovary to 
replenish the stock of primordial follicles. A lack of follicular renewal in aging 
ovaries may cause an accumulation of spontaneously arising or environmentally 
induced genetic alterations of oocytes, explaining why the oocytes in primary follicles 
among aging females have a higher incidence of genetic alterations [Bukovsky et al., 
2005]. 
1.7 THE KINETICS OF PRIMORDIAL FOLLICLE DEPLETION IN YOUNG AND 
ADULT MICE 
Following recent studies on germline stem cells and follicular renewal in the mouse 
ovary [Johnson et al. 2004, 2005a], Kerr and collaborators hypothesized that total, and 
particularly primordial, healthy follicle numbers should remain relatively constant, at 
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least for a significant part of adult reproductive life [Kerr et al., 2006]. Using unbiased 
stereological methods, immune-labeling of meiosis (germ cell nuclear antigen and 
ovarian cell proliferation) and electron microscopy, all healthy follicles in mouse 
ovaries were quantified at various time points after birth. After a marked depletion of 
follicles and oocytes during the first postnatal week, the mean number of primordial 
follicle per ovary did not decline significantly in mice and no significant decay in the 
total numbers of all healthy follicles was observed [Kerr et al., 2006]. Oocytes and 
primordial follicles were found either in the surface epithelium or in the periovarian 
space and migrated to these locations through the tunica albuginea [Kerr et al., 2006]. 
Byskov & Rasmussen [Byskov & Rasmussen, 1973] estimated that 5–10 % of 
oocytes or primordial follicles were associated with the OSE. 
The concept, that new oocytes and follicles arising from surface epithelial cells of the 
postnatal mouse ovary was suggested in as early as 1917 by Kingery [Kingery 1917].   
However, Kerr and collaborators present no evidence for conversion of surface 
epithelial cells into oocytes. In contrast, the group around Kerr suggests an alternative 
explanation: oocytes with or without associated stromal cells were exiting the ovary 
via the surface epithelium rather than arising from it [Kerr et al., 2006]. 
Although the proof of the existence of the ovarian germline stem cells in the postnatal 
and adult mouse ovary remains to be established, they suggested that primordial 
follicle numbers remain relatively constant in association with simultaneous, active 
folliculogenesis therefore the group support yet unknown mechanism for follicle 
renewal [Kerr et al., 2006]. 
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1.8 OOGENESIS IN DROSOPHILA MELANOGASTER. 
Many tissues including blood, skin, gut and germ cells are continuously maintained 
by tissue stem cells [Spradling et al, 2001; Watt et al, 2000]. Under certain conditions, 
however, other tissues can undergo repair using stem-cell-like progenitors generated 
by cell de-differentiation [Stocum, 2000; [Mikkola et al., 2002; Morrison et al., 2000; 
Prohaska et al., 2002; Pearson et al., 2003].  
In the fruit fly Drosophila melanogaster, both spermatogenesis and oogenesis rely on 
germ-line stem cells. Similarities in the structural and molecular strategies used by the 
two sexes in germline stem cell maintenance and differentiation include the tight 
control that somatic support cells exert on every aspect of germline stem cell function 
and the similar molecular mechanisms for physical attachment, cell-cell signaling and 
gap-junction communication [Gilboa et al., 2004]. Some common principles 
underlying germline stem cell biology in the fly may be applied to other organisms. 
According to common beliefs, the stem cell stage is unique in the life cycle of the 
germ cell. Recent findings suggest that the germline stem cells may not be as 
distinctive as we used to think. By definite circumstances in both males and females, a 
germline stem cell successor cells (the developing cyst) can revert and form germline 
stem cells again [Kai and Spradling, 2004]. It suggests that the somatic cells 
surrounding the germ cell greatly influence its developmental state, as they form a 
niche.  
Kai and Spradling report that Drosophila gremlin stem cell successor cells convert 
into single stem cell-like cells. These de-differentiated cells can again develop into 
functional germline stem cells and support normal fertility [Kai and Spradling, 2004]. 
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Results show that a germline stem cell successor cells represent a relatively good 
source of regenerative precursors that might help replenish germ cells after depletion 
by genotoxic chemicals, radiation or normal ageing. Drosophila cystocytes provide a 
system for studying de-differentiation and its potential as a source of functional stem 
cells [Kai and Spradling, 2004]. 
1.9 CASE REPORTS INDICATING THE POTENTIAL OF RENEWAL OF THE 
OVARIAN FOLLICLE POOL IN ADULT WOMEN 
One of the most devastating effects of the current treatment of cancer is the damage of 
the reproductive system, which in young girls and women less than 40 years old is 
frequently leading to premature menopause and infertility [Meirow et al., 2001; 
Wenzel et al., 2005; Lee et al., 2006; Desmeules et al., 2006; Raz et al., 2002; Lopez 
et al., 2004]. This outcome seems to be, in large part, a result of cytotoxic effects of 
chemotherapy on the germ cells (e.g. the oocytes) in the ovaries. Thus, experimental 
trials aiming at sustaining fertility in female cancer survivors have been directed 
merely at preservation of existing oocytes [Meirow et al., 2001; Wenzel et al., 2005 ; 
Lee et al., 2006; Tilly et al.,, 2001; Morita et al., 2000; Paris et al., 2002]. 
However, although early menopause frequently occurs in female patients, suffering of 
cancer and treated withr chemotherapy (CT) and/or bone marrow (BM) 
transplantation (BMT), has been linked to an unexplained return of ovarian function 
and fertility in some survivors. In few women, treated with cytotoxic agents still 
during reproductive life and subsequently diagnosed with premature menopause, have 
been observed with an unexpected return of ovarian function and fertility after bone 
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marrow (BM) transplantation (BMT) [Salooja et al., 1994; Sanders et al., 1996; 
Salooja et al., 2001; Hershlag et al., 2002]. 
Mesenchymal stem cells (MSC) residing within the BM microenvironment are 
pluripotent adult stem cells, whose multipotency, easy isolation and culture as well as 
high ex vivo expansive potential make them attractive candidates for stem cell therapy 
[Vats et al., 2005]. Successful attempts of BM-derived MSC transplantation for 
repairing spinal, cardiac and skin injuries have been already reported [Orlic et al., 
2001; Fu et al., 2006]. MSC have attracted interest for their possible use for both cell 
and gene therapies because of their capacity for self-renewal and multipotency 
[Prockop et al., 1997]. Transplantation of MSC directly into adult rat brain and heart 
reduces functional deficits resulting from stroke [Li et al., 2000] and acute obstruction 
of the heart muscle [Orlic et al., 2001], respectively. One of the mechanisms behind 
this is the integration of MSC into the tissue and replacement of damaged cells. In 
addition, the mediators secreted by MSC might be involved in the repair by 
preventing cell apoptosis and promoting functional recovery [Xu et al., 2007]. 
Premature ovarian failure (POF) as a consequence of childhood cancer treatment is 
considered permanent when present long after the initial therapy. POF in girls is a 
known complication of CT and radiation and has been estimated to occur in 
approximately 6 % of childhood cancer survivors [Chemaitilly et al. 2006].  
However recovery of ovarian function after cancer treatment has been reported in 
single cases involving older children and adults.   
The case report [Rahhal et al., 2008] describes a patient who received chemotherapy 
and radiation as leukaemia and growth hormone deficiency treatment. The patient was 
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exposed to total body irradiation, which is a major risk factor for the development of 
permanent ovarian failure [Chemaitilly et al., 2006; Sklar, 2005]. This treatment was 
followed by allogenic cord blood transplantation. Rahhal et al. report spontaneous 
recovery of ovarian function occurring 8 years after transplantation in the adolescent 
patient with history of cancer [Rahhal et al., 2008]. Rahhal et al suggest that recovery 
of ovarian function is possible after cancer treatment and after treatment with sex 
steroids [Rahhal et al., 2008].  
As described before, new ovarian follicles may be generated in the mouse by germline 
stem cells supplied by the BM via the circulatory system [Johnson et al, 2004]. These 
authors have postulated clinical applications of their findings and have suggested that 
a blood transfusion alone might solve infertility through such a mechanism. However, 
these postulations have generated a harsh controversy and have ignited much 
opposition [Telfer et al, 2005, Eggan et al, 2006]. Notably, transplantation and 
parabiotic mouse models have failed to provide evidence that BM cells, or any other 
circulating cells, or even soluble factors, contribute to the formation of mature 
ovulated oocytes [Eggan et al, 2006].  
Considering the above-mentioned results, one can question whether recovery of 
fertility might result from a repopulation of the ovary or by the circulating donor’s 
germline stem cells. The existence of germline stem cells in human would bring many 
ethical, social and psychological implications for BM donors, receivers, and offspring. 
To clarify this issue, Veitia and collaborators examined a clinical situation of a 
woman who gave birth to a child after allogeneic BMT. Despite patient clinical 
background of chemotherapy and radiotherapy cancer treatment, she became pregnant 
and delivered a healthy child [Veitia et al., 2007]. The DNA from the mother 
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(patient), the daughter, and the donor were analyzed. The genetic relationship between 
the mother and the daughter clearly demonstrated no genetic inheritance from the 
donor. As such, Veitia and collaborators data provide clear evidence against the 
hypothesis from Johnson et al. [Johnson et al., 2004; Johnson et al., 2005] that BMT 
is responsible for fertility recovery by supplying GSCs [Veitia et al., 2007]. The 
recovery of fertility after BMT seems to better explained by the incomplete depletion 
of the ovarian follicle reserve. 
Additional data have shown that, unlike after irradiation, chemotherapy does not 
completely sterilize female mice and allows a small population of residual 
endogenous oocytes and/or germ cells to survive to later restore ovulation [Eggan et 
al., 2006].  
1.10 MESENCHYMAL STEM CELLS TRANSPLANTATION MAINTAIN 
DAMAGED TISSUE 
Mesenchymal stem cell (MSC) transplantation can improve the structure and function 
of injured tissues. Fu and colleagues performed a study exploring the therapeutic 
potency of MSC transplantation in order to repair ovarian damage caused by CT in 
rats [Fu et al., 2008]. The group claims improvement of damaged ovarian function 
and reduced apoptosis of granulosa cells (GC) of the rats exposed to CT injection 
after MSC transplantation, probably by the mediators secreted by MSC [Fu et al., 
2008]. They demonstrated that MSC secrete cytokines in vitro, thereby inhibiting CT-
induced cell apoptosis protecting the GC against the cytotoxic chemotherapeutics.  
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MSC secrete significant amounts of VEGF, IGF-1 and HGF in vitro, which raises the 
possibility that MSC-derived cytokines may participate in follicular growth. VEGF is 
an angiogenic cytokine that promotes the proliferation of endothelial cells and 
formation of new vessels [Shin et al., 2006]. IGF-1, a growth hormone mediator, can 
stimulate GC proliferation, inhibit apoptosis and promote follicular antrum formation 
[Mao et al., 2004; Sirotkin et al., 2002]. HGF is a cytokine which is involved in 
promoting follicle maturation, cell growth required for folliculogenesis [Ito et al., 
2001; Nilsson et al., 2001] and in suppressing apoptosis in GC and follicle cultures 
[Uzumcu et al., 2006]. 
After transplantation of MSC, MSC-derived cells were found in the ovarian tissue, but 
not within ovarian follicles. These results demonstrate that transplanted MSC may 
play an important role in supporting and promoting the ovarian microenvironment. 
However, it is unlikely that these MSC can differentiate into oocytes or GC [Fu et al., 
2008]. 
Using a preclinical mouse model of CT-induced ovarian failure, Lee and collaborators 
observed a reversal of long-term infertility in CT-treated females by BMT that was 
influenced by several aspects. The most important were the time of the transplantation 
after CT, the amount of CT and the timing of mating initiation after BMT [Lee at al., 
2007]. All of the offspring produced by CT-treated females and after BMT were 
derived from the recipient germline, despite the fact that the presence of donor BM–
derived oocytes in their ovaries was suggested. Donor-derived oocytes were only 
observed in immature follicles up to the preantral stage of development but never 
observed in maturing antral or Graafian follicles from which ovulated eggs are 
derived.  
  
- 22 - 
BMT supports long-term fertility improvement in CT-treated females, but all 
offspring was derived from the recipient germline. Cell tracking showed that donor-
derived oocytes were generated in ovaries of recipients after BMT. It is claimed that 
donor-derived immature oocytes detected in the ovaries of female mice after 
transplantation actually represent immune cells [Eggan et al., 2006].  Lee and 
collaborators suggest that BMT functions mainly by reactivating host oogenesis as a 
near-complete reversal of infertility in mice was achieved, when BMT was performed 
after CT at the time when the cytotoxic drugs were already removed from the body 
[Lee at al., 2007].  
It is also possible that CT damages the ovaries such that engraftment or differentiation 
of germ cells fails to occur unless the gonadal microenvironment is repaired by the 
transplanted somatic cells or by factors released from the transplanted cells. This line 
of reasoning would be explained by recent studies of male germline stem-cell function 
in mice, in which the microenvironment was identified as principal cause of 
spermatogenic failure. 
Adult bone-marrow-derived MSC in a favourable environment capable of 
differentiation along several tissue-forming cells such as bone, cartilage, fat, muscle, 
liver, kidney, heart, and even brain cells [Grove et al., 2004; Jiang et al., 2002]. Lue at 
al reported adult stem cell differentiation in the testis of busulfan-treated wild-type 
mice after bone marrow cells transplantation [Lue et al., 2007]. They state, a few 
weeks after transplantation the transplanted bone marrow cells were found in recipient 
testes [Lue et al., 2007]. However the bone marrow derived germ cells halted at the 
early spermatocyte stage without further differentiation into mature sperm. The 
mechanisms of donor-derived germ cells that failed to produce mature cells still 
  
- 23 - 
remain unknown. In addition, the possibility of fusion of donor cells with native germ 
cells cannot completely be excluded. Observation of Lue at al. suggests an essential 
role of recovering endogenous germ cells in the proper microenvironment [Lue et al., 
2007].  
Nayernia and collaborators demonstrated that somatic adult BMS cells could 
differentiate into male germ cells [Nayernia et al., 2004]. BMS cell-derived germ cells 
expressed all known molecular markers of primordial germ cells, as well as molecular 
markers of spermatogonial stem cells and spermatogonia [Nayernia et al., 2004]. They 
state that BMS cells are able to differentiate to early germ cells, PGCs and even 
spermatogonia in vitro and in vivo. However a similar developmental arrest in 
spermatogonia derived from male BM cells transplanted into adult mouse testes as in 
Lue at al work was reported [Nayernia et al., 2006; Lue et al., 2007]. 
Studies published recently are challenging the outlook on infertility and germ cell 
development. They present male and female gametes can be produced in vitro from 
embryonic or teratocarcinoma stem cells from established population of primordial 
germ cell-like cells after transplantation into the testes or ovaries or by extending 
cultures [Nayernia et al., 2004; Geijsen et al., 2004; Toyooka et al., 2003; Hubner et 
al., 2003]. 
Generally speaking, cell regeneration and replacement in the adult is dependent on 
tissue-specific stem cells. The specific stem cell in adult proliferates and differentiates 
into mature cell types that correspond to the tissue of origin and do not generate cell 
types of different lineages [Weissman, 2000]. However, more recent literature has 
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challenged this notion and demonstrated stem cells crossing tissue boundaries in 
response to a microenvironmental signaling [Wagers et al., 2004; Kucia et al., 2005].  
As previously shown by Lue and colleagues, the resident neighboring cells in the 
recipient testis may control site-appropriate stem cell differentiation. This clinically 
relevant finding raises the possibility for treatment of infertility in men through the 
therapeutic use of stem cells [Lue et al., 2007].  
1.11 CRITICAL ARGUMENTS AGAINST THE RENEWAL OF THE POOL OF 
OVARIAN FOLLICLES AFTER BIRTH 
It seems highly unlikely that the human species evolved a mechanism, by which adult 
women are able to renew their germline cell pool. In effect, this creates a situation 
where eggs would then be placed at risk for cumulative damage from aging and 
external harm before being used to possibly generate offspring. 
Recent data [Johnson et al., 2005a] not only reinforced this controversy but also 
surprisingly suggested that the BM is a potential source of oocyte-producing germ 
cells in adults. However, this study has been met with much skepticism. Doubts raised 
in commentaries on this work are largely based on inaccurate or incomplete 
assessments of experimental models and results [Johnson et al., 2005b].  
Since the publication of two papers challenging the long-standing dogma that 
mammalian females are incapable of postnatal oocyte and follicle production 
(Johnson et al., 2004, 2005a), this topic has been the subject of at least 11 critical 
commentaries, that have voiced varying degrees of skepticism if not outright disbelief 
[Albertini, 2004; Gosden, 2004; Greenfeld and Flaws, 2004; Hoyer, 2004; Telfer, 
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2004; Ainsworth, 2005; Byskov et al., 2005; Gougeon, 2005; Powell, 2005; Telfer et 
al., 2005; Vogel, 2005].  
One of the striking features of the mammalian ovary is the disappearance of oocytes 
through atresia, a process that begins early in life and proceeds until no more follicles 
are present in old age. In the mouse more than half the growing follicles will become 
atretic by day 21 after birth [Byskov, 1978]. Johnson found that atretic follicles only 
accumulate from day 30 onwards, and they assume that the number of 1,200 atretic 
follicles present on day 42 is so high that the oocyte pool would soon have 
disappeared provided new oocytes would not be formed instead. Thus, the pool of 
atretic follicles observed on day 30 by Johnson and coworkers [Johnson et al., 2004] 
most likely represents follicular remnants that have been degenerating previously 
[Byskov et al., 2005]. 
The primordial follicle depletion rate is usually estimated based upon the 
mathematical model given by Faddy et al. [Faddy et al., 1987], which predicts a day 
to day of loss of primordial follicles. Thus, the difference of existing follicles versus 
follicles depletion rate would represent the number of new follicles produced. It must 
be mentioned that the estimated loss of follicles [Faddy et al., 1987] is based on a 
different strain of mouse than the one used by Johnson and collaborators and the loss 
of ovarian follicles is known to differ greatly among various strains [Jones and Krohn, 
1960; Faddy et al., 1983; Canning et al., 2003].  
Johnson and collaborators [Johnson et al., 2004] further claim that functional 
germline stem cells reside in the surface epithelium of the adult mouse ovary and that 
they can give rise to new follicles. It has been shown previously that primordial 
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follicles may leave the ovary through the surface epithelium, particularly during early 
stages of development. In the prepubertal mouse primordial follicles accumulate in 
the bursal cavity surrounding the ovaries [Byskov and Rasmussen, 1973]. Thus, the 
large ovoid germ cells in the surface epithelium may also be primordial follicles 
instead of transitory stages of the first meiotic prophase [Byskov et al., 2005].  
Oogenesis is the process that transforms the proliferative oogonium into an oocyte 
through meiosis, followed by folliculogenesis and follicular and oocyte maturation. 
The most crucial part in producing a functional oocyte is firstly, initiation and 
completion of the first meiotic prophase, and secondly, enclosure of the resulting 
diplotene oocyte in a follicle. Neither of these two events have been shown to take 
place in Johnson’s study of the postnatal mouse ovary [Byskov et al., 2005].  
Moreover, experiments have demonstrated that the ovarian surface epithelium is not 
needed for maintenance of follicle growth. The growing follicles and corpora lutea 
would still develop in the ovaries of rat, guinea-pig, cat, and opossum up to one year 
after destruction of the ovarian surface epithelium [Moore and Wang, 1947; Mandl et 
al., 1952; Mandl and Zuckerman, 1949]. Byskov and collaborators found no 
convincing evidence for a functioning “germinal” epithelium with new oocytes in 
prophase of meiosis [Byskov et al., 2005]. 
An interesting chimaeric ovarian model was created by combining fractions of wild-
type and ubiquitous green fluorescent protein (GFP) transgenic ovaries [Johnson et 
al., 2004] and the authors hypothesized that new follicles were formed. Previous 
studies revealed that small follicles can be disaggregated and reformed spontaneously 
[Gosden, 1990], even when combining cell types of separate species [Eppig and 
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Wigglesworth, 2000]. Thus, it is suspected that the new observations reflect 
primordial ovarian plasticity and that chimaerism was a product of tissue injury after 
transplantation rather than being because of the generation of follicles de novo 
[Byskov et al., 2005]. 
To explore the idea on the extragonadal origin of germ cells in adult mammalian 
females, one may compare observations in animals with and without ovaries 
[Bukovsky, 2005b].  Johnson et al. [Johnson et al., 2005a] reported that the germ cell 
formation in BM disappears in ovariectomized mice. This observation may be 
considered as evidence for the ovarian origin of germ cells, which may enter the 
ovarian blood stream and, therefore, into the BM too [Bukovsky, 2005b].  
Another important aspect is the presence of primitive granulosa cell clusters 
resembling fetal ovaries [Bukovsky, 2005a]. A re-colonization of adult human ovaries 
with new primary follicles would require the presence of such primitive granulosa cell 
nests. In other words, even transplantation of autologous germ cells may not be 
sufficient for follicular renewal in aging women, which lack nests of primitive 
granulosa cells in their ovaries [Bukovsky, 2004].  
To investigate directly the capacity of naturally circulating peripheral blood cells to 
engraft in the ovary and contribute to oogenesis, Eggan and collaborators examined 
ovulated oocytes from adult female mice surgically joined by parabiosis [Eggan et al., 
2006]. Parabiotic mice develop a common circulatory system and exhibit continuous, 
rapid exchange of cells and other circulating factors through the bloodstream [Bunster 
et al., 1933; Wright et al., 2001]. Thus, parabiosis allows direct tracking of genetically 
marked cells supplied continuously and at physiological levels through the circulation 
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and provides a powerful approach to determine whether blood-derived factors 
normally contribute to ovarian function or repair [Wright et al., 2001; Conboy et al., 
2005; Sherwood et al., 2004; Wagers et al., 2002]. In contrast to the substantial 
chimerism evident in the peripheral blood of long-term parabionts, no chimerism of 
oocytes was observed in parabiotic mice [Eggan et al., 2006]. Occasionally cells 
observed associated with in the cumulus mass of ovulated oocytes originated from 
circulating blood cells [Eggan et al., 2006]. Thus, although circulating cells have the 
capacity to enter the ovary and to associate with ovulating oocytes, they maintain all 
haematopoietic features in this environment and did not contribute to the production 
of ovulated oocytes [Eggan et al., 2006]. 
Previous transplantation experiments have demonstrated that donor BM stem cells can 
undergo spontaneous fusion with differentiated host cells [Weimann et al. 2003; 
Alvarez-Dolado et al. 2003]. Haematopoietic stem cells and primordial germ cells 
develop in close proximity during embryogenesis and in vitro experiments have 
demonstrated that primordial germ cells can exhibit some of haematopoietic 
characteristics [Rich 1995].  It remained possible that damage to the bone marrow, 
ovary, or germ cells might be required to enable ovarian engraftment of circulating 
cells. Non-transgenic mice were pre-treated with CT [Johnson et al., 2005a; 
Shiromizu et al., 1984; Burkl et al., 1978; Mattison et al., 1981; Meirow et al., 2001] 
and then joined with untreated transgenic partners. However, in great contrast to the 
cross-engraftment evident in the haematopoietic lineages, no evidence for cross-
engraftment of circulating oocyte precursors in parabiotic mice was found [Eggan et 
al., 2006]. 
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A significant decline in the total numbers of oocytes ovulated by CT treated animals 
over time was observed, but CT did not cause complete depletion of the reserve of 
oocytes in the treated parabiotic mice. Furthermore, both maturing and mature 
follicles were observed in some histological sections, although CT-induced damage to 
the ovaries was widespread [Eggan et al., 2006].  
The possibility that direct intravenous transplantation of bone marrow cells introduces 
cells into the blood circulation that are not normally present in the bloodstream but are 
capable of contributing to or stimulating oogenesis was also verified. As CT does not 
always lead to a complete depletion of the oocytes pool, animals sterilized by low-
dose total body irradiation were also examined. Again, in contrast to the 
haematopoietic engraftment evident in mice transplanted with bone marrow, no 
evidence of bone marrow derived oocytes in parabiotic mice was found [Eggan et al., 
2006]. In addition, no oocytes were found in the oviducts of animals pre-treated with 
irradiation, whether or not they received bone marrow transplants [Eggan et al., 
2006]. 
1.12 THE EMINENT ROLE OF SURROUNDING SOMATIC STEM CELLS IN 
FOLLICULOGENESIS  
The ovary contains a pool of inactive primordial follicles. Each follicle contains a 
small non-growing oocyte and a single layer of non-dividing cells encapsulated by the 
follicular basal lamina [Gougeon, 1996]. As part of an ongoing process, primordial 
follicles become active, and the oocyte starts to grow and its surrounding granulosa 
cells start to become mitotic. As the granulosa cells divide, the number of layers of 
granulosa cells (called the membrane granulosa or follicular epithelium) around the 
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oocyte increases, and the basal lamina expands [Rodgers et al., 1999; Rodgers et al., 
2001]. Primordial follicles give rise to primary follicles which transform into preantral 
(secondary follicles) then antral follicles (tertiary follicles) and finally preovulatory 
and Graafian follicles, in a co-ordinated series of transitions regulated by hormones 
and local intraovarian factors [Gougeon, 1996; Gomez et al., 1999; Vigo et al., 2005]. 
Primordial follicles are not distributed uniformly in the ovary, but are predominantly 
located in the ovarian cortex. The ovarian cortex is covered by a layer of irregular 
shaped cells [Van Blerkom  et al., 1979], commonly known as the ovarian “germinal” 
or surface epithelium (SE), which is attached to the TA. In functional human ovaries 
the SE is found in certain areas only, but in women with polycystic ovaries, the 
ovarian surface is completely covered with SE [Makabe et al., 1980]. These 
observations indicate that the SE-derived epithelial nests may represent primitive 
granulosa cells. They may either invade SE from adjacent structures and are extruded 
from the ovary [Motta, 1986]. 
In adult human females, mesenchymal cells in the ovarian tunica albuginea (TA) 
undergo a mesenchymal–epithelial transition into OSE cells, which may differentiate 
sequentially into primitive granulosa and germ cells. TA is a thick fibrous 
subepithelial layer with cells embedded in loose connective-tissue, which does not 
begin to form until the end of intrauterine life [Motta, 1986; Simkins, 1932]. These 
structures assemble in the deeper ovarian cortex and may form new follicles to 
replace earlier primary follicles undergoing atresia (Fig 1) [Bukovsky et al., 2005].  In 
other words, in adult human ovaries, surface epithelial cells derived from the tunica 
albuginea, have been reported to differentiate into granulosa cells and oocytes 
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forming new follicles [Bukovsky et al. 1995, 2004, Bukovsky 2005] but full proof of 
this observation is still lacking.  
 
 
Figure 1. Working model of possible pathways for formation of primary follicles in 
adult human ovaries [Bukovsky et al., 2005].  
The mammalian ovary produces mature oocytes capable of being fertilized and 
sustaining early embryonic development. Developmental competence of the oocyte 
correlates with follicular size, larger oocytes being more developmentally competent 
[Bachvarova et al., 1980; Berkholtz et al., 2006]. The development of an oocyte 
ultimately capable of undergoing fertilization and embryogenesis depends on 
appropriate signalling from surrounding ovarian granulosa cells (GCs) including 
follicle-stimulating hormone (FSH) [Thomas et al., 2007] 
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Conventional thinking considers the ovarian follicle as an isolated structure, distinct 
both in space and time, either destined for early degeneration through atresia or for 
growth to a mature, Graafian follicle, ovulation and formation of the corpus luteum. 
The cyclicity of follicular development, ovulation and luteal function are seen as 
discrete phenomena. In recent years, however, experimental evidence has shed some 
doubt on this conventional thinking. Most notably, it has been demonstrated that 
mature and fully grown mouse oocytes are able to influence the development of 
preantral follicles in mouse ovaries [Cecconi & Rossi, 2001], indicating interdepends 
of the cyclic events in the ovary. In addition to these early observations, other 
investigators were able to demonstrate that upon ovulation, the epithelioid granulosa 
cells redifferentiate into the mesenchymal cells of the corpus luteum [Rodgers et al., 
1999].  
Despite years of research little is still known of the cellular biology of developing 
follicles. This is unfortunate as there are some very interesting features of developing 
follicles, which have remained outside the scope of experimental research 
[Amsterdam et al., 1987; Hirshfield, 1991]. The membrana granulosa or follicular 
epithelium is more complex than most other epithelia for various reasons: at first it 
expands from a single to a multi-layered epithelium as the follicle grows. In the 
transition from a pre- to a post-antral follicle, the shape of GC change from non-
dividing flattened appearance to dividing cubical appearance. The epithelium also 
expands laterally with time as the follicle enlarges. During the preovulatory phase the 
membrana granulosa becomes vascularised with capillaries sprouting from the 
surrounding theca interna. Finally, the granulosa becomes degraded upon ovulation 
and the remaining GCs are thought to differentiate into luteal cells. It is the faith of 99 
% of all follicles to become atretic and apoptosis among the granulosa cells is one of 
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the first indicators of follicular atresia [Seifer et al., 1993; Rodgers et al., 1999; 
Berkholtz et al., 2006].  
1.13 BEHAVIOUR OF HUMAN GRANULOSA CELLS DURING THEIR CULTURE 
IN VITRO 
Human granulosa cells are recovered as waste during transvaginal ultrasound-guided 
oocyte collection in assisted reproduction technology (ART), either for in vitro 
fertilization (IVF) or for intracytoplasmic sperm injection (ICSI). The main 
characteristics of these differentiating cells are mitochondria clustering, increased 
number of lipid droplets, microvilli, and clustering granulosa cells forming lumen-like 
structures [O’Shea, 1987; Zhang et al., 2000]. The culture of granulosa cells in vitro 
will promote luteinization resulting in apoptosis after a few days.   
Though GCs are deeply related with human ovarian function and various 
dysfunctions, little has been known because of their short life span in vitro. Most of 
studies on the ovarian functions have been provided by using subhuman primates and 
non-primate animals [Okamura et al., 2003] and result from short-term cultures in 
vitro. Existing immortalized human granulosa cell lines, obtained from developing 
follicles or ovarian carcinomas, showed little steroid hormone biosynthesis and/or 
limited detectable expression of the genes characteristics for GCs markers [Lie et al., 
1996; Hosokawa et al., 1998; Zhang et al., 2000; Nishi et al., 2001; Okamura et al., 
2003]. Immortalized human GC lines are useful for study follicular and oocyte 
maturation in vitro, however, those lines are not physiological as most of them were 
established from a primary human GC tumor or were established by transfection of 
luteinizing GC.  
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It has been postulated that during follicular growth granulosa cells arise from a 
population of stem cells [Lavranos et al., 1996; Rodgers et al., 1995a; Rodgers et al., 
1996]. It is predicted that some or all of the early granulosa cells surrounding the 
oocytes of primordial follicles are committed stem cells, although inactive ones. This 
model encompasses stem cells, transiting amplifying cells (replicating and 
specializing), and differentiating cells. The progeny of stem cells, the transit 
amplifying cells, can further replicate during follicular growth a limited number of 
times before they differentiate into specialized cells as well [Rodgers et al., 2001]. It 
is clear that all GCs have not the equal potential to divide [Rodgers et al., 1999]. 
However, the question is whether the various granulose cell layers actually contain 
different cell types, or merely the same cells of different ages or stages of 
development. In any event, studies in the mouse have suggested that basal and antral 
GCs can be derived from the same progenitor cells [Boland et al., 1994]. Therefore, 
the cells that gave rise to them must have been pluripotent. In addition, studies by 
Honda and collaborators [Honda et al., 2007] provide evidence for the presence of 
stem cells in the neonatal mouse ovary – the thecal stem cells.  
If indeed GCs arise from stem cells and if stem cells exist within the follicle, then the 
in vitro culture of such cells should be possible. Moreover, cells that are stem cells 
have the capacity to differentiate into others cell lines. 
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2 AIMS OF THE THESIS 
The first part of this study has been performed to confirm the presence of pluripotent 
or multipotent stem cell populations among granulosa cells collected from mature 
human ovarian follicles. This work includes attempts to promote the growth of GCs 
over prolonged time periods in vitro. Previous studies in our laboratory have 
demonstrated that this is not possible with culture media which contain FSH and 
androgens [Zhang et al., 2000]. We identify the specific markers for mesenchymal 
stem cells and mature GCs and differentiate luteinizing GCs into other cell types of 
the mesenchymal lineage. 
In the second part we demonstrate that granulosa cells can indeed be maintained in 
vitro thereby preserving their main characteristics, including the FSH receptor and 
steroidogenesis.  
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3.1 ABSTRACT 
Graafian ovarian follicles consist of follicular fluid, one single mature oocyte and 
several hundred thousands of granulosa cells (GC). Until now, luteinizing GCs are 
considered to be terminally differentiated, destined to undergo death after ovulation. 
Present concepts of luteal function, endocrine regulation of early pregnancy and the 
recruitment of new ovarian follicles are all based on the cyclical renewal of the entire 
population of GC. We demonstrate that luteinizing GC isolated from the ovarian 
follicles of infertile patients and sorted with flow cytometry based upon the presence 
of their specific marker, the follicle stimulating hormone receptor (FSHR) can be 
maintained in culture over prolonged periods of time in the presence of the leukemia-
inhibiting factor (LIF). Under those conditions the markers of GC function such as 
FSHR and aromatase gradually disappeared. POU5F1, a typical stem cell marker, was 
expressed throughout the culture, but not germ line cell markers such as nanog, vasa 
and stellar. Mesenchymal lineage markers such as CD29, CD44, CD90, CD105, 
CD117 and CD166, but not CD73, were expressed by substantial subpopulations of 
GC. The multipotency of a subset of GC was established by in vitro differentiation 
into other cell types, otherwise not present within ovarian follicles, such as neurons, 
chondrocytes and osteoblasts. Follicle-derived stem cells were also able to survive 
when transplanted into the back of immuno-incompetent mice, in vivo generating 
tissues of mesenchymal origin. The unexpected findings of multipotency of cells with 
prolonged lifespan originating from ovarian follicles are likely to have a significant 
impact on evolving theories in ovarian pathophysiology, particularly with reference to 
the ovarian endometriosis and ovarian cancer. 
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3.2 INTRODUCTION 
3.2.1 THE GROWTH OF FOLLICLE 
Having been laid down in fetal ovaries, the primordial follicles remain quiescent for 
decades. Once their development starts, they give rise to primary follicles, which are 
characterized by a slow growth of the enclosed oocyte and by low GC proliferation 
rates [Gougeon et al., 1996]. After their transformation into primary follicles, both the 
oocyte´s growth and the proliferation of the granulosa gain momentum culminating in 
the rapid growth of the antral follicle, finally resulting in the development of the 
mature Graafian follicle destined for ovulation. Several hundreds of thousands of GC 
exert a multitude of specialized functions encompassing the function of the follicle, 
such as producing large amounts of estradiol, adapting its FSH- and luteinizing 
hormone-receptivity to the endocrine milieu, nursing the oocyte and communicating 
both with the enclosed oocyte and the surrounding thecal cells. The signalling leading 
to ovulation results in luteinization of the tissue. Luteinized GC are considered to be 
terminally differentiated, being replaced in the midluteal phase of the menstrual cycle 
by small, luteinized cells originating from the surrounding theca [Niswender et al., 
2000]. 
3.2.2 STEM CELLS 
Both the rapid proliferation of the GC within the growing follicle and the exertion of 
such a large variety of specialized functions can only be thought of by accepting the 
notion, that the population of GC in a healthy follicle is not uniform, but rather 
consists of subpopulations of differentiated and less differentiated cells, the latter 
being more capable of mitosis. A similar situation is encountered in other rapidly 
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proliferating tissues with specialized functions, such as the bone marrow. The bone 
marrow contains a variety of specialized haematopoietic cells, such as myelocytes, 
reticulocytes or megakaryocytes, but also undifferentiated cells, which possess many 
of the characteristics contributed to stem cells. Within the particular anatomical 
environment of the bone marrow, stem cells are first capable of proliferation, then of 
differentiation, thereby steadily replacing ageing and apoptotic haematopoietic cells 
[http://stemcells.nih.gov/]. Other examples are found throughout the body, such as the 
intestines, the brain, the placenta and the testis [Young et al., 2005]. However, in 
contrast to many other tissue types, cells with stem cell properties have not yet been 
described within ovarian follicles. 
3.2.3 OVERVIEW 
The present communication is the first to describe, how luteinizing GC can be 
cultured over prolonged time periods under conditions similar to those known to 
support the survival of adult stem cells. We characterized a subpopulation of these 
cells, either shortly after their collection or after prolonged periods of culture in vitro, 
and demonstrated that these cells under appropriate conditions both in vitro and in 
vivo can be differentiated into other cell types, normally not encountered in the ovary. 
In this way, for the first time we were able to establish the multipotency of a 
subpopulation of cells collected from the antrum of human ovarian follicles. 
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3.3 MATERIAL AND METHODS 
3.3.1 COLLECTING OF LUTEINIZING GC 
Luteinizing GCs were collected by transvaginal ultrasound-guided aspiration from 
infertile patients treated with controlled ovarian hyperstimulation for assisted 
reproduction. Patients were treated with various exogenous gonadotropin including 
human menopausal gonadotropin (HMG, Menopur, Ferring, Switzerland; Merional, 
IBSA, Switzerland), and recombinant FSH (Gonal F, Serono, Switzerland; Puregon, 
Organon, Switzerland) followed by 10’000IU of human chorionic gonadotropin 
(HCG, Pregnyl, Organon). After removal of the cumulus oophorus-oocyte-complexes 
(COC), the freshly collected follicular aspirates were centrifuged for 5 min, 111g. 
GCs were separated from other cells by density gradient centrifugation on 5ml Ficoll 
PLUS (Amersham Bioscences, Sweden) for 20 min, 391g. GC were clearly visible in 
the interphase layer, isolated by pipetting, washed twice in 10ml Dulbecco’s modified 
Eagle’s (DMEM) culture medium and centrifuged again at 111g for 5 min for final 
collection of the cells [Zhang et al., 2000]. The purified cells were placed in freezing 
medium (fetal calf serum, FCS with 10% (v/v) dimethylsulphoxide (DMSO) and 
stored at –80ºC until flow cytometry (FACS, Fluorescence Activated Cell Sorter). In 
order to reduce inter-patient variability, each experiment was performed with mixed 
populations of GC collected from at least 8 patients after an informed consent 
obtained from each patient. This study was approved by our local Ethical Committee. 
3.3.2 CELL CULTURE 
GC were cultured in DMEM containing a high concentration of glucose (4500mg/L, 
Gibco, Switzerland), supplemented with 15% (v/v) fetal calf serum (Gibco), 
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penicillin/streptomycin (50μg/ml), L-glutamine (3mmol/l), β-mercaptoethanol (10mM 
stock solution in DMEM), recombinant FSH (100ng/ml or 3 x 10-4 IU/ml, Gonal F; 
Serono) and 1000 IU/ml of leukaemia inhibing factor [Gough et al., 1988] (LIF, 
Chemicon International, USA). As cells were highly sensitive to trypsin, a cell scraper 
was used for passages. Identical culture conditions were used for the incubation of 
bone marrow stromal cells in order to check for a potential contamination with 
fibroblasts.  
3.3.3 IDENTIFICATION OF THE LUTEINIZING GC USING FACS AND SORTING 
GCs were identified by the presence of FSHR and subsequently sorted using FACS. 
GC identification and sorting was performed by a dual labelling technique, where 
GCs were identified as CD3-negative cells, distinguishing them from CD3-positive 
leukocytes (anti-CD3-APC monoclonal mouse antibodies – Becton Dickinson) [De 
Neubourg et al., 1998]. GCs were kept frozen at –80°C and were thawed on the day of 
performing FACS. The first polyclonal goat antibody, raised against a peptide 
mapping near N-terminus of the FSHR of human origin (Santa-Cruz Biotechnology), 
was added for 30 min, kept on ice in the dark. The second donkey anti-goat IgG 
antibody labelled with fluorescence isothiocyanate (FITC) (Santa-Cruz 
Biotechnology) was used incubating for 30 min on ice in the dark. Isotype controls 
were used. Isolated populations of FSHR-positive cells, considered to be pure GC, 
were used for prolonged culture. As GCs were cultured either immediately after their 
aspiration from ovarian follicles or after thawing, their viability was tested using 
propidium iodide (pI) exclusion or calcein tests (Live/Dead Kit, Invitrogen). 
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3.3.4 FLUORESCENCE-ACTIVATED CELL SORTING ANALYSIS 
Cell suspensions were incubated for 30 min at 4°C with fluorochrome-conjugated 
antibodies against the indicated protein or an isotype control. All antibodies were 
purchased from Becton Dickinson except the one against CD105 (Serotec) and FSHR 
(Santa-Cruz Biotechnology). Cells were washed, resuspended in PBS and analyzed 
with FACSCalibur (Becton Dickinson). 
3.3.5 RT-PCR 
Total RNA was extracted from GC using a RNeasy Total RNA kit from Qiagen 
(Germany). The quantity of RNA was measured by optical density at A260 nm (ND-
1000 Spectrophotometer, NanoDrop Technologies, USA). Total RNA (1μg) was 
reverse transcribed into single strand cDNA using the cDNA synthesis kit 
(Boehringer Mannheim, Mannheim, Germany). Primers were synthesized by 
Microsynth, Switzerland: FSHR F (forward) 5’TGGGCTGGATTTTTGCTTTTG, R 
(reversed) 5’CCTTGGATGGGTGTTGTGGAC (annealing temperature 55°C, DNA 
product size 529 bp); Aromatase F5’CAAGTGGCTGAGGCAT, 
R5’GAGAATAGTCGGTGAA (55°C, 429 bp); POU5F1 (OCT-4)  [Abdel-Rahman 
et al., 1995]; stellar [Ezeh et al., 2005]; vasa [Ezeh et al., 2005]; nanog [Ezeh et al., 
2005]; LIFR [Abir et al., 2004]; nestin [Scintu et al., 2006]; neurofilament (NF) 
[Scintu et al., 2006]; B-3-tubulin [Dozier et al., 2003]. cDNA amplification primers 
for POU5F1, FSHR and LIF-receptor (LIFR) were designed to span introns as to 
eliminate genomic DNA contamination. The β-actin PCR product was used as internal 
control (Rapid Scan). The single strand cDNA was subjected to 35 cycles of PCR 
amplification using one of the primer sets. The amplified products were separated on 
1 or 2% agarose gels. The RT-PCR products were analyzed by DNA sequencing 
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(ABI, PE Applied Biosystems, USA), mRNA from bone marrow was used as a 
positive control for POU5F1 [Pochampally et al., 2004]. 
3.3.6 IMMUNOHISTOCHEMISTRY 
For the morphological examination of freshly collected or frozen/thawed GC were 
fixed in 1% paraformaldehyde overnight at 4°C, stained with haematoxylin/eosin 
(H&E) and observed microscopically at various magnifications (Leitz, Dialux 20, 
Germany). The presence of FSHR and POU5F1 in GC was demonstrated with 
immunohistochemistry using an antibody against human FSHR (Santa-Cruz 
Biotechnology) and POU5F1 (Abcam), respectively, following standard protocols. 
The secondary antibody against FSHR consisted of FITC-labelled donkey anti-goat 
antibodies (Santa-Cruz Biotechnology). The secondary antibodies against POU5F1 
consisted of biotin-conjugated rabbit anti-goat antibodies (DAKO, Denmark A/S) or 
donkey anti-rabbit TexRed. Stainings for immunohistochemistry were performed by 
incubation with the ABC-alkaline phosphatase complex kit (Dako, Glostrup, 
Denmark), counterstained with H&E and mounted. As positive controls for the 
detection of POU5F1 sections of mouse ovaries were used.  
3.3.7 DIFFERENTIATION IN VITRO 
The multilineage differentiation capacity of the sorted luteinizing GC was evaluated 
by their differentiation into cell types, normally not encountered within the antrum of 
ovarian follicles, such as neuronal cells, osteoblasts and chondrocytes. Freshly 
collected and sorted GC were cultured in neuro-inductive medium for 10 days. For 
differentation of GC after long-term culture in vitro, GC were first incubated in 
medium supplemented with LIF for two weeks, then three weeks in one of the three 
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specific differentiation media described below. After five weeks, the pellets were 
harvested for histological examination and gene expression analysis. 
Differentiation towards the neurogenic lineage was induced by DMEM supplemented 
with 10 %FCS and 30μmol/L transretinoic acid (Sigma) [Portmann-Lanz et al., 2006]. 
Differentiation towards the chondrogenic lineage was induced in DMEM culture 
medium supplemented with 10% FCS, ITS-1 (Insulin, Transferrin, Selenium; Sigma), 
0.1mM ascorbic acid 2-phosphate, 10ng/ml TGFβ1 and 10-7M dexamethasone 
[Barbero et al., 2003]. Osteogenic differentiation was induced in DMEM culture 
medium supplemented with 10%FCS, 0.1mM ascorbic acid 2-phosphate, 10-2M β-
glycerophosphate and 10-8M dexamethasone [Barbero et al., 2003]. Neuro-
differentiation was performed in monolayers. Chondro-differentiation was performed 
in three-dimensional (3D) cell cultures [Barbero et al., 2003], osteo-differentiation in 
both. For the 3D-cell culture approximately 3.5x105 cells were cultured in pellets in 
conical microtubes (Sarstedt) on an orbital shaker. The media were changed three 
times weekly. For histological examination pellets were fixed in 4% formalin 
overnight at 4°C, paraffin embedded and sectioned (7um thickness). The sections 
collected from the osteogenic culture medium and the respective controls were stained 
with H&E or incubated for 10 minutes with alizarin red, washed extensively with 
water and observed microscopically (Leitz, Dialux 20, Germany). An alternative 
procedure consisted of staining with an antibody against bone sialoprotein (anti-BSP, 
Immundiagnostik AG, Germany). Decalcification of osteo-differentiated pellets was 
performed with Osteodec (Bio-Optica, Italy). The sections after chondroinduction 
were stained with Safranin-O or Alcian Blue. 
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3.3.8 QUANTITATIVE REAL-TIME PCR 
Primers for real-time PCR were synthesized by Microsynth: COLL1, COLL2, OC 
[Barbero et al., 2003], OP F5’ CTC AGG CCA GTT GCA GCC, R5’ CAA AAG 
CAA ATC ACT GCA ATT CTC or synthesized by Roche: BSP [Barbero et al., 
2003], SOX9 F5’CCCGCACTTGCACAACG, R5’TCCACGAAGGGCCGCT. 
Power SYBR Green PCR Master Mix (AB Applied Biosystems) for real-time PCR 
and TaqMan GAPDH Control Reagent (PE Applied Biosystems) was used as internal 
control. cDNA was subjected to 40 cycles of amplification using ABI PRISM 7000 
Sequence Detector System (AB Applied Biosystems). Expression of the different 
genes was presented as percentage of expression of GAPDH, a house-keeping gene, 
by using the formula: 1/2ΔCt. Where ΔCt=gene–GAPDH, ΔCtq=control gene–
GAPDH, ΔΔCt=ΔCt-ΔCtq and Delta-Delta CT Method, fold change, was presented 
using the formula: 2– ΔΔCt. 
3.3.9 DIFFERENTIATION IN VIVO 
The multilineage differentation capacity of GC was assessed by implantation into the 
back of immuno-incompetent mice. For that purpose GC were cultured in vitro for 
three weeks in 3D and transplanted in nude mice (CD-1 nu/nu, 1-month old; Charles 
River Laboratories, Wilmington, MA, http://www.criver.com) in accordance with 
institutional guidelines. Four to eight weeks after implantation, the mice were 
sacrificed. The constructs were harvested and fixed overnight in 1% 
paraformaldehyde, paraffin embedded and sectioned. Sections were then stained by 
H&E and observed microscopically. Immunohistochemistry for BSP was performed 
with a BSP-biotin conjugated antibody (Cedarlane labs) followed by incubation with 
ABC-alkaline phosphatase complex (Dako, Glostrup, Denmark), counterstained with 
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H&E and mounted. For immunohistofluorescence of BSP, polyclonal rabbit-anti-
human BSP antibodies from Alexis Biochemicals with secondary goat anti-rabbit PE 
antibodies from Becton Dickinson were used. To distinguish human from murine cells 
immunohistofluorescence was carried out with anti-human monoclonal HLA-ABC-
biotin conjugated (Cedarlane Laboratories Ltd) antibody with avidin-FITC secondary 
antibodies from Becton Dickinson. Some sections were also stained with Safranin O 
to assess the formation of cartilage. 
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3.4 RESULTS 
3.4.1 PURE POPULATION OF GC 
The cellular content of follicular fluid aspirated during oocyte collection for assisted 
reproduction consisted of a mixture of luteinizing GC, both single and in clumps, 
erythrocytes and large epithelial cells, probably also arising from the vaginal 
epithelium. Most of the erythrocytes were excluded during the Ficoll density gradient 
purification. With FACS a subpopulation of FSHR bearing cells from the follicular 
aspirates was consistently identified and separated from any contaminating cells. As 
illustrated in supplemental Figure 1 (Fig.1), the relative number of cells expressing 
FSHR among the entire population of cells in the unsorted follicular aspirates ranged 
between 7% and 50%.  
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Figure 1. FACS analysis for FSHR (B and D) and isotype control (A and C) for two 
IVF patients labeled 001 (A and B) and 002 (C and D). M1 – cells negative for 
FSHR, M2 – cells positive for FSHR. As presented, population of GC from single 
patient is very different. Therefore all experiments were performed with mixed 
population of GC from different patients. 
This broad range corresponds to the individual characteristics of infertile women, 
from whom the GC were collected, and to the technical variabilities of transvaginal, 
ultrasound-guided aspiration of ovarian follices. Pooling of GC from different patients 
was used to overcome this variability. After sorting and adhesion to the culture dish 
all cells expressed the FSHR, as demonstrated both by cytofluorimetry and 
immunocytochemistry (Fig.2A, B, C). After thawing and sorting, approximately 40% 
of GC survived after one day in culture (Fig.3). The sorted cells were characterized as 
luteinizing GC through their expression of both FSHR and aromatase (Fig.6A).  These 
purified luteinizing GC were then used for prolonged culture. 
3.4.2 LIF EFFECT ON GC CULTURE 
In order to evaluate the effect of LIF on the prolonged survival of GC in vitro, sorted 
luteinizing GC were split into two groups and cultured separately. One group was 
cultured in DMEM medium supplemented with LIF, while another group without 
LIF. The expression of LIFR in sorted luteinizing GC was first confirmed (Fig.4). The 
luteinizing GC cultured without LIF consistently died within two weeks (Fig.2D), 
whereas those cultured in medium supplemented with LIF remained viable for up to 
four months and could be passaged (Fig.2E, F). After 7 days with LIF, GC retained 
their morphology, constructed intercellular connections and became strongly attached 
to the culture dish (Fig.5). In contrast, GC cultured in the absence of LIF became 
folded after 7 days (green arrow) and lost intercellular connections (red arrow). 
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Moreover, expression of FSHR remained present for at least 7 days in cells cultured 
with LIF, whereas it was mostly lost after 7 days in the absence of LIF (Fig.5).  
 
 
Figure 2.  Purification and long-term culture of luteinizing GC. FSHR in GC (A, B, 
C). (A) FACS/sorting results of freshly collected GC. (B) Pure population of GC after 
FACS/re-sorting of already sorted cells. Cells: (R2) FSHR-positive, (R3) CD3-
positive. (C) Immunocytochemistry of GC for FSHR after FSHR sorting. GC cultured 
in medium: (D) after 5 days without LIF, (E) after 5 days in the presence of  LIF, (F) 
after 1 month in the presence of LIF.  
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Figure 3. Viability test for frozen/thawed GC positive for FSHR. For experiments 
mixture of GC were used. There was no difference observed in experiments with only 
frozen/thawed or mixed population of GC. 
 
 
Figure 4. Characterization of luteinizing GC, sorted with FACS and cultured in 
medium supplemented with LIF. Expression of LIFR.  
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Figure 5. Survival of GC. GC cultured with LIF kept their morphology and were 
strongly attached to the dish. Cells were big and spread in a bigger area (black 
arrow). Cells keep contact to each others. GC cultured without LIF after 7 days are 
starting to fold the cytoplasm (green arrow) and therefore break the contact with 
other cells (red arrow).  
Sorted GC upon FSHR show 100% positivity of FSHR marker after ICC when 
cultured in monolayer (day 2 of culture with LIF and without LIF). After day 7 of 
culture in monolayer GC keep the FSHR in about 40% cells when cultured with LIF. 
When cultured without LIF only about 10% of cells present weak staining for FSHR. 
3.4.3 GC PHENOTYPE 
The expression of FSHR, aromatase and POU5F1 (POU domain, class 5, homeobox 
1) was then examined on sorted luteinizing GC cultured in the presence of LIF at 
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various time intervals (after 7, 21, 28 and 56 days) and compared with freshly 
collected sorted and unsorted luteinizing GC (Fig.6A). After approximately 7 days the 
luteinizing GC progressively lost their ability to express FSHR, after 8 weeks also that 
of aromatase. POU5F1 was expressed in the freshly collected luteinizing GC and 
remained expressed in the luteinizing GC throughout their culture in medium 
supplemented with LIF (Fig.6A).  
The expression of POU5F1 was confirmed by immunocytochemistry in the nucleus of 
some GC attached to unmarked GC (Fig.6B). The same immunostaining for POU5F1 
in both oocytes and GC inside antral follicles of mouse ovaries was used as a positive 
control (Fig.7). Double stainings for FSHR and POU5F1 were performed in GC after 
1, 3, 5, 7 and 9 days in culture to examine whether the FSHR-expressing GC were co-
expressing POU5F1 and to exclude any contamination of extrafollicular stem cells. 
Throughout culture in the presence of LIF, 1-3% of GC expressing FSHR also 
expressed POU5F1 (Fig.8 and Fig.9). Additionally, the potential overgrowth of the 
GC culture by contaminating fibroblasts or other cells was excluded by the 
observation that no cells survived in the absence of LIF. Furthermore, in another set 
of experiments bone marrow stromal cells were cultured in the same medium either 
supplemented or not supplemented with LIF. Under those conditions the bone marrow 
stromal cells remained viable over prolonged time periods in both media and 
expressed neither FSHR nor POU5F1 (Fig.10). 
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Figure 6. Characterization of luteinizing GC. Characterization of luteinizing GC, 
sorted with FACS and cultured in medium supplemented with LIF. (A) RT-PCR 
analysis shows progressive loss of FSHR/aromatase expression during prolonged 
culture, but not of POU5F1 (OCT4). RT+/-: negative control, M: marker, fGC-freshly 
collected GC, sGC-sorted GC, cultured GC after: 1-1w (week), 3-3w, etc. (B) 
POU5F1 staining of GC. Three GC stained for POU5F1 are visible. Two GC are 
fibroblast-type cells (asterisk and black arrow). One GC is epidermal-type cell and 
did not attach to the culture dish (green arrow). One GC presents the negative 
nucleus staining (asterisk), one with positive nucleus staining (black arrow). In both 
cells cytoplasm is negative for POU5F1 staining (asterisk and black arrow). (C)  
Epithelial-like and (D) fibroblast-like morphology of GC after 10 days culture. (E) 
Immunophenotyping results for GC-derived multipotent cells. The following markers 
of mesenchymal stem cells were detected: CD29, CD44, CD105, CD117, CD166 
whereas CD73 was negative. The red line indicates the respective markers, the grey 
shaded area the isotype control. 
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Figure 7. (A) Oct4 (POU5F1) immunohistochemistry in sections of mouse ovaries 
(magnification 10x). (B) negative control.  
 As visualized with light microscopy, cultured luteinizing GC exhibited two distinct 
morphologies: epithelial (between 5% and 35% of all cells) or fibroblastic (Fig.6C, 
D). The epithelial-like cells disappeared after about 3 weeks in culture, whereas the 
remaining cells retained their fibroblastic morphology.  
 
 
Figure 8. Immunocytofluorescence for GC cultured in monolayer. (A) Light 
microscopy image. (B) FSHR-FITC staining. (C) POU5F1-TexRed staining. (D) 
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Double staining with FSHR-FITC and POU5F1-TexRed presenting FSHR GC 
positive for POU5F1. 
 
 
Figure 9. The relative number of stained cells (%) for FSHR and POUF5F1 during 
their observation in culture medium either supplemented with LIF (black columns) or 
without LIF (empty columns). The heighth of each column represents the median with 
the 95 % confidence interval. Using Kruskal-Wallis statistically significant 
differences were found: a, b and c denote a statistically significant difference 
p<0.0001 at day 5, 7 and 9, respectively, as compared with day 1 and 2, resp., equally 
for cells cultured in the presence of LIF and without LIF; d denotes a statistically 
significant difference between the relative number of cells stained between culture 
with and without LIF. 
 
 
Figure 10. RT-PCR for bone marrow stromal cells (BM)  
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3.4.4 PLURIPOTENCY OF GC 
As the transcription factor POU5F1 remained expressed throughout the prolonged 
culture, we examined other markers of pluripotency, characteristic for germ cells, 
such as nanog, stellar and vasa (Fig.11). All specific markers of germ cells, however, 
were negative. All PCR products yielded the expected fragment sizes. There was no 
contamination of genomic DNA in any of the samples tested and all negative controls 
(RT±) processed without reverse transcriptase yielded no amplification product.  
 
 
 
Figure 11. Characterization of luteinizing GCs, sorted with FACS and cultured in 
medium supplemented with LIF. The germ cells markers vasa, stellar and nanog were 
not expressed in GCs. RT-PCR of mouse ovary as a positive control for Vasa, Stellar 
and Nanog. 
3.4.5 MESENCHYMAL STEM CELLS MARKERS 
As GC originates from the mesoderm, we subsequently examined the mesenchymal 
cells characteristic of the freshly collected GC using various markers of mesenchymal 
stem cells (MSC). Cells were positive for markers: CD29, CD44, CD90 CD105, 
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CD117 and CD166, but not CD73 (Fig.6E). CD117 was positive in only 4.5% (+/- 
3%) of GC (mean +/- standard deviation, 10 different donors). The typical marker for 
hematopoietic cells, CD45, was present only in freshly isolated GC probably due to a 
contamination with blood cells, although CD34 was not expressed (data not shown). 
3.4.6 NEURODIFFERENTIATION 
The multipotency of a subpopulation of cells in the follicular aspirates was assessed. 
Neuronal markers for neurodifferentiation of freshly isolated GC were thus examined. 
Two neuronal markers, nestin and β-3-tubulin, were weakly expressed in freshly 
collected GC, whereas another, neurofilament, was not found to be expressed in 
freshly collected GC (Fig.12). Subsequently, the multilineage differentiation capacity 
of GC was assessed after prolonged culture. The cells were differentiated in vitro to 
neuronal, osteoblastic and chondrogenic lineages respectively under conditions 
known to direct the differentiation of MSC. A clonal analysis of GC was attempted, 
but failed probably due to the deleterious effect of trypsin and the increased general 
sensitivity of passaged GC. The capacity of luteinizing GC to undergo neurogenic 
differentiation after prolonged culture in medium supplemented with LIF was 
examined as well. After five days GC cultured as monolayers in medium containing 
retinoic acid developed neuron-like structures. After 8 days of culture, approximately 
15 % of all cells displayed the distinct morphology suggestive of neurons 
(Fig.13A,B). Various neuronal markers, such as nestin, neurofilament and β-3-
tubulin, were found to be expressed in GC cultured in retinoic acid-enriched medium 
but not in the control medium supplemented with LIF (Fig.13C). All experiments 
were performed in triplicate. Brain tissue was used as a positive control and the 
expression of all markers was confirmed by sequencing (data not shown).  
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Figure 12. RT-PCR for neurodifferentiation markers of freshly isolated GC presents 
only 2 genes (nestin and BIIITubulin - arrows) weakly expressed, where the NF - 
neurofilament gene is not expressed. RA – medium with retinoid acid; LIF – medium 
with LIF; RT- – negative control. 
 
 
Figure 13. Neurogenic differentiation of GC. Neurogenic differentiation of GC after 
prolonged culture in medium supplemented with LIF. (A, B) Neuron-like morphology 
after neurogenic induction of GC. (C) RT-PCR results of GC-neural induction 
showing expression of the neuronal markers, nestin (N), B-3-tubulin (T) and neuro-3-
filament (NF). GC: GC cultured in control medium supplemented with LIF, sGC: 
sorted GC. 
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3.4.7 THE OSTEOBLASTIC DIFFERENTIATION 
The osteoblastic differentiation potential of cultured luteinizing GC was examined by 
alizarin red and BSP-staining and gene expression of various osteoblastic markers, 
such as BSP, osteocalcin (OC) and osteopontin (OP). As GCs cultured as monolayers 
in osteoinductive medium exhibited typical changes in their cellular morphology 
(Fig.14), but were too sensitive and became detached from the culture plate, a 3D-
culture system was introduced. Under those conditions and in the presence of an 
osteo-inductive medium,  previously luteinizing GC were stained positively with 
alizarin red and marked with anti-BSP antibodies, whereas the same cells cultured in 
medium supplemented with LIF or sections of mouse ovaries remained negative 
(Fig.15). The matrix of osteo-differentiated cell pellets was demonstrated to be 
mineralized, as documented by rapid dissolution of crystallized structures by 
treatment with an acidic decalcification buffer, Osteodec® (data not shown). Real-time 
PCR showed that expression of BSP was increased 14-fold, OP 66-fold and OC 3-fold 
in osteo-differentiated tissue pellets, when compared to control cells cultured with 
medium supplemented with LIF (Fig.14B). When compared with bone marrow-
derived cells (BMSC) cultured as a monolayer in a similar osteoinductive medium 
during the same time [Frank et al., 2002], BSP was found to be expressed 8 times 
more in BMSC than in osteo-differentiated GC pellets, but both OP and OC were 
expressed more in the GC pellets (5 and 1.5-fold respectively). 
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Figure 14. Osteogenic differentiation of GC. GC cultured in monolayers (A) in 
control medium exhibiting fibroblast-like cells and in osteo-inductive medium after 5 
days, showing epithelial-like morphology of cells. (B) Real time PCR results for BSP, 
OP and OC expression in control GC, GC after osteodifferentiation and in bone 
marrow stem cells (BMSC). 
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Figure 15. Osteogenic differentiation of GC. Osteogenic differentiation of GC after 
prolonged culture in medium supplemented with LIF.  (A, B, C) Stainings for alizarin 
red and (D, E, F) BSP for 3D-cultured luteinizing GC and sections of mouse ovaries.  
3.4.8 THE CHONDROGENIC DIFFERENTIATION 
The chondrogenic differentiation potential of luteinizing GC cultured over prolonged 
periods of time was demonstrated by the presence of glycosaminoglycan (GAG) in 
GC pellets cultured in 3D in chondro-inductive medium using Safranin-O-staining 
(Fig.16A, B). After chondrogenic differentiation, the tissue sections were weakly 
positive for Safranin-O-staining, whereas GC cultured in medium supplemented with 
LIF were negative. Sections of mouse ovary were also negative for GAG-staining 
(data not shown). With real-time PCR the expression of various genes specific for 
chondrogenic differentiation was upregulated in GC cultured in chondrogenic 
differentiation medium, when compared to GC cultured with control medium with 
LIF: collagen-1 (Coll1) 4.5-fold, collagen-2 (Coll2) 6.5-fold and Sox9 12.5-fold 
(Fig.16C). These values were also compared with expanded primary chondrocytes 
cultured as a monolayer in the same chondrogenic medium during the same period 
[Barbero et al., 2003]. Expression of Coll2 and Sox9 was higher in chondrocytes (2.5-
fold and 1.9-fold respectively), but that of Coll1 was higher in chondro-induced GC 
(1.6-fold). 
3.4.9 IN VIVO DIFFERENTIATION 
The capacity of GC cultured in medium supplemented with LIF to survive and 
differentiate in vivo into other, distinct tissue types was examined through 
subcutaneous transplantation into the back of immuno-incompetent, nude mice. The 
implants were harvested either four weeks or eight weeks after transplantation. After 
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eight weeks the implanted cell pellets appeared to be more integrated within the 
murine tissue than after 4 weeks (Fig.17A, B) and expression of BSP was detected 
(Fig.17C, D, F). Those cells were always surrounded by murine cells also showing 
expression of BSP (Fig.17E, F). The distinct origin of both cell types was tested by 
HLA-ABC-staining, which is specific for human tissue. Eight weeks after 
transplantation some GAG deposition was also detected as demonstrated through the 
Safranin-0-staining (Fig.17G, H, I). 
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Figure 16. Chondrogenic differentiation of GC. Chondrogenic differentiation of GC 
after prolonged culture in medium supplemented with LIF. (A) Safranin-O staining in 
control GC and (B) in GC after chondro-induction. Real time PCR results (C) for 
expression of COLL1, COLL2, Sox9 in control GC in regular culture medium, GC 
after chondroinduction and in chondrocytes. 
 
 
Figure 17. In vivo differentiation of GC. HLA-ABC (green) staining of pellets 
containing GC, (A) 8 weeks after implantation at 20x magnification and (B) 4 weeks 
after implantation, at 10x magnification. Staining for BSP using 
immunohistochemistry, (C) 8 weeks after transplantation (red) at 20x magnification, 
(D) BSP using immunohistofluorescence (red) at 20x magnification, and (E) for 
HLA-ABC (green) at 20x magnification. (F) Double staining for BSP and HLA-ABC 
at 20x magnification. (G) Staining for Safranin-O, 8 weeks after transplantation (red) 
  
- 64 - 
at 10x magnification and (H) HLA-ABC 10x. (I) Double staining for Safranin-O and 
HLA-ABC, magnification 10x.  
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3.5 DISCUSSION 
3.5.1 LIF IMPACT ON CULTURE 
Up to now, luteinizing GCs are considered to be terminally differentiated, 
unavoidably becoming apoptotic a few days after ovulation. Indeed, prolonged culture 
in vitro of GC collected from preovulatory follicles has not been possible beyond 10 
days. Instead, various researchers have attempted to use GC from granulosa tumors 
[Zhang et al., 2000; Nishi et al., 2001] or immortalized GC [Tajima et al., 2002] in 
order to construct GC lines suitable for research purposes. We were now able to 
culture luteinizing GC, collected from infertile women treated with controlled ovarian 
hyperstimulation for assisted reproduction, over prolonged time periods. The variable 
fertility status of single patients certainly impacts on GC function. Therefore, in all 
experiments the samples of several patients were pooled in order to reduce this 
potential confounding factor. The crucial difference between our present approach 
and earlier trials [Zhang et al., 2000] was the use of LIF, a cytokine commonly used 
in culture media supporting the development and growth of stem cells. LIF promoted 
the long-term survival of luteinizing GC, whereas in the absence of LIF these cells 
invariably became apoptotic. LIF is a glycoprotein with a remarkable range of 
biological actions in different tissues, such as long-term maintenance of mouse, but 
not human embryonic stem cells [Daheron et al., 2004]. In a number of tissues LIF 
has been shown to be important for stem cell self-renewal, such as the brain [Bauer et 
al., 2006], the gut [Kalabis et al., 2003] and bone marrow [Jiang et al., 2002]. 
LIF has been detected both in fetal and adult human ovaries [Abir et al., 2004] and 
may be involved in the transition of primordial to primary follicles [Nilsson et al., 
2002]. LIF is present in the follicular fluid and its secretion can be enhanced by 
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human chorionic gonadotropin [Arici et al., 2997; Coskun et al., 1998]. LIF receptor 
activity has been detected in oocytes and preimplantation human embryos [Van Eijk 
et al., 1996], suggesting a role of genital tract LIF in the process of follicular 
development and implantation [Arici et al., 1995]. 
3.5.2 GC PHENOTYPE 
Although LIF permitted the prolonged survival of luteinizing GC, they progressively 
lost their major characteristics, such as the FSHR and aromatase. The overgrowth of 
the luteinizing GC by a subpopulation of other cells such as fibroblasts was excluded 
by the extraction of a pure population of GC with FACS based on the FSHR. Apart 
perhaps from the oocyte [Meduri et al., 2002], GC are the only cell type in the female 
body possessing the FSHR. Both with flow cytometry and immunocytochemistry we 
demonstrated that all experiments were performed with a highly homogeneous and 
almost pure population of GC. The sorted GC continued to possess all typical 
characteristics such as aromatase and FSHR over a period of at least ten days. As 
follicles mature, the amount of mRNA for FSHR is known to decrease, whereas that 
of aromatase increases [Slomczynska et al., 2001]. The presence of FSHR in sorted 
GC was confirmed by immunocytochemistry. 
The two different morphologies of GC, epithelial and fibroblastic, found to be present 
in the medium during initial culture, correspond to the different intrafollicular 
locations, from which the GC were removed during transvaginal ultrasound-guided 
follicular aspiration. There is evidence that GC originating from the close to the basal 
membrane are columnar, whereas those originating from the middle layer are rounded 
and those originating from the central part of the follicle, close to oocyte, are flattened 
[Rodgers et al., 2001]. Some authors argue that the elongated GC may have lost 
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aromatase activity, cytoplasmic changes compatible with luteinization [Gutierrez et 
al., 1997]. When cultured in monolayers, GCs invariably become luteinized and 
convert their epithelial morphology into a fibroblastic one, explaining why the latter 
morphology became dominant during prolonged culture. 
3.5.3 STEM CELLS PROPERTIES OF GC 
The progressive loss of all characteristics of GC during prolonged culture and the 
continued expression of POU5F1 in luteinizing GC gave rise to the hypothesis that 
some follicular cells might exhibit stem cell properties. POU5F1, also known as OCT-
4A, is a transcription factor and one of the two isoforms produced by the OCT-4 gene, 
which is considered as a main regulator of differentiation and self-renewal [Pan et al., 
2002; Cauffman et al., 2006; Liedtke et al., 2007; Zangrossi et al., 2007; Kotoula et 
al., 2008]. The expression of POU5F1 has not been demonstrated in granulosa before. 
Using immunostaining we confirmed the presence of POU5F1 in the nucleus of 
human GC and in mouse ovaries. 
To confirm the multipotency of GC, we first examined typical mesenchymal markers 
of multipotent MSC. With the exception of CD73, subpopulations of GC expressed 
those markers, thereby adding to the notion that during prolonged culture in the 
presence of LIF these cells possess many but not all attributes of the MSC lineage. 
We then provided evidence of the multipotency of a GC subpopulation by 
demonstrating their differentiation potential when cultured with specific 
neuroinductive, chondroinductive and osteoinductive culture media. 
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3.5.4 CHONDRODIFFERENTIATION  
Chondroinduction was demonstrated by real-time PCR and detection of GAG, a 
method commonly used for the detection of cartilage matrix [Barbero et al., 2003]. 
Safranin-O-staining was used, because the Alcian Blue staining, commonly applied 
for GAG-staining, also stained Call-Exner bodies in ovarian tissue, as described 
previously [Van Wezel et al., 1999]. Safranin-O-staining was weak, probably due to 
the fact that some GC died early during the chondrogenic differentiation. Expression 
patterns of cartilage-related genes during chondrogenic differentiation in GC and 
expanded primary chondrocytes control were similar. The COLL1 and COLL2 genes 
are expressed during cartilage development. COLL1 is expressed by cells first 
entering differentiation where COLL2 is expressed in differentiated cells 
[Bonaventure et al., 1994]. SOX9 is a key regulator of chondrogenesis [Jenkins et al., 
2005]. The difference in expression levels of the three genes could suggest that GC, 
under the conditions described, undergo very early chondrogenic differentiation.    
3.5.5 OSTEOBLASTIC DIFFERENTIATION 
Osteoblastic differentiation was demonstrated by alizarin-red-staining, a dye assessing 
the presence of calcium in mineralized matrices. BSP-staining was also performed 
and confirmed the osteoblastic differentiation of GC. BSP and OP are prominent 
components of bone extracellular matrix. They are expressed by differentiated 
osteoblastic cells and serve as indicators of osteoblastic differentiation of BMSC 
[Barbero et al., 2003]. After 3 weeks of osteoblastic differentiation, the expression of 
BSP messenger RNA exhibited a 14-fold increase and OP messenger RNA a 66-fold 
increase as compared to GC cultured in LIF medium. OC messenger RNA showed a 
limited 3-fold increase in differentiated GC. This low expression level is explained by 
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OC starting to be expressed later during the osteoblastic differentiation process, 
between days 16-30 of culture, resulting in a maximal though limited expression at 
day 21. 
3.5.6 NEURODIFFERENTIATION 
The differentiation potential of GC into the neuronal lineage was less pronounced 
among freshly isolated GC than after prolonged culture. Neuro-induction of freshly 
collected GC induced the expression of only two neuronal markers, nestin and β-3-
tubulin, but not neurofilament. Obviously, the size of the subpopulation of GC with 
multipotent stem-cell characteristics is smaller shortly after follicular aspiration than 
after prolonged culture. 
3.5.7 DIFFERENTIATION POTENTIAL OF GC 
As some MSC markers were not uniformly present in the sorted GC and although we 
can not entirely exclude the overgrowth of the sorted GC by contaminating 
mesenchymal stem cells admixed from other tissues and expanding during prolonged 
culture, we hypothesize the presence of several subpopulations of GC in preovulatory 
follicles, each expressing different MSC markers according to their degree of 
differentiation. In many organs, adult tissues typically contain various cell 
populations, including multipotent stem, progenitor cells and terminally differentiated 
cells [Hochedlinger et al., 2006].  
For the first time, prolonged culture of luteinizing GC in medium supplemented with 
LIF allows the selection of less differentiated GC, which exhibited a certain degree of 
plasticity, as they could be differentiated in vitro into three distinct lineages: neuronal, 
chondrocytic and osteoblastic, all normally not found in healthy ovarian follicles. 
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Both the survival of GC after prolonged culture in the presence of LIF and their 
ability to differentiate into cells of the mesodermal lineage was also confirmed in 
vivo. The transplanted and differentiated human cells were surrounded by specific 
mouse cells differentiated into the same direction, all within mesenchymal lineage. 
3.5.8 OOGENESIS – RECENT DEBATE  
Recently, much controversy has arisen concerning the possible presence of stem cells 
in the germinal layer of the mouse ovary and their potential for replacing germ cells 
postnatally [Johnson et al., 2004]. The ovarian surface epithelium of adult human 
females as well as bone marrow MSC was reported to be a source of germ cells 
[Bukovsky et al., 2005]. However, the possibility that the luteinizing GC cultured in 
the presence of LIF were germ cells was ruled out by the lack of expression of nanog, 
vasa and stellar. 
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3.6 CONCLUSIONS   
The high concentration of LIF in the follicular fluid of mature follicles and the 
presence of LIFR in GC both suggest that our findings physiologically relevant. 
Multipotent stem cells in ovarian follicles may be involved in the early origin of some 
forms of ovarian cancer as well as to the origin of ovarian endometriosis, which is 
considered to arise from undifferentiated, metaplastic cells in the ovary. This 
hypothesis is supported by the abundant secretion of LIF by endometrial cells [Arici 
et al., 1995]. Evidence for the presence of stem cells in the ovarian follicle was 
provided recently by the identification of stem cells from the thecal layer in the 
neonatal mouse ovary [Honda et al., 2007]. A model of how GC arises from a 
population of stem cells has been discussed previously [Rodgers et al., 1999]. Here, 
we demonstrate the presence of multipotent follicular cells, characterized as GC, 
which survive in the presence of LIF. 
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4.1 ABSTRACT 
The most common cell type in preovulatory ovarian follicles are luteinizing granulosa 
cells (GCs), which are considered as terminally differentiated undergoing cell death 
only few days after ovulation. We recently demonstrated that GCs cultured as 
monolayers remain viable in vitro over prolonged time periods when the culture 
medium is supplemented with the leukaemia inhibiting factor (LIF). However, under 
those conditions, GCs rapidly lose their main characteristics, such as follicle-
stimulating hormone receptor (FSHR) and cytochrome P450 aromatase. Here, we 
describe a three-dimensional (3D) pellet culture system containing type I collagen, 
which together with LIF allowed not only the survival and growth of primary human 
GCs, but supported a significant subpopulation of GCs to maintain their 
characteristics for prolonged time periods. GCs progressively organized into spherical 
follicle-like structures with patches of cells expressing the FSHR surrounded by cells 
producing collagen type IV, reminiscent of the basal membrane. In those structure 
Call-Exner bodies were observed. The steroidogenic capacity the GCs after prolonged 
culture in 3D was further demonstrated by the presence of both P450-aromatase and 
3β-hydroxysteroid dehydrogenase (3β-HSD). After transplantation into the ovaries of 
immunoincompetent mice the GCs became concentrated within follicles and the 
prolonged expression of the FSHR was confirmed. This studies document that it is 
possible to culture human GC collected from preovulatory follicles over prolonged 
time periods while retaining their functional characteristics. 
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4.2 INTRODUCTION 
4.2.1 GRANULOSA CELLS IN THE FOLLICLE  
Particularly during the final stages of follicular growth, which culminates in the 
release of a mature oocyte during ovulation, GCs are at the centre of ovarian function. 
On the one hand, they form a functional syncitium surrounding and nursing the 
oocyte, on the other  they produce the bulk of steroids, which are secreted into blood 
circulation to orchestrate the various organs of the female body for successful 
ovulation, the oocyte`s fertilization and subsequent implantation of the embryo. 
During the final stages of antral follicle growth, the proliferation, differentiation and 
function of GCs are initially controlled by the follicle-stimulating hormone (FSH) 
alone, later by both FSH and luteinizing hormone (LH). FSH targets its receptor 
(FSHR) and induces the maturation of ovarian follicles through proliferation of GCs, 
induction of the LH-receptor (LHR) and formation of a functional syncitium 
[Buccione et al., 1990; Dias, 2002; Themmen et al., 2000; Drummond, 2006]. 
Functional GCs express 3β-hydroxysteroid dehydrogenase (3β-HSD) [Wang et al., 
1995; Richards, 1994], an enzyme which plays an important role in synthesis of 
various steroid hormones, particularly progesterone [Frindik, 2008], whereas 
cytochrome P450 aromatase is required for the production of estradiol. 
4.2.2 PREVIOUS STUDIES  
Research focusing on GC function, particularly in the human, has been severely 
hampered by the impossibility to culture these cells over prolonged time periods due 
to the spontaneous luteinization of GCs followed by spontaneous cell death within 
few days [Channing et al., 1975; Channing et al., 1978; Luck, 1990]. We previously 
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demonstrated that human luteinizing GCs can be maintained in vitro over prolonged 
time periods in culture medium supplemented with LIF and that a subpopulation 
exhibits multipotent stem cell-like properties [Kossowska-Tomaszczuk et al., 2009]. 
However, even in the presence of LIF GCs cultured in monolayers gradually lost their 
characteristics such as aromatase and FSHR. Similarly, during spontaneous 
luteinization of GCs in vitro, the initially globular GCs progressively loose their 
ability to express aromatase, FSHR but also collagen type IV (Coll IV) [Zhao et al, 
1996]. 
4.2.3 EXTRA-CELLULAR MATRIX 
Coll IV-fibers are the principal component of the follicular basal membrane which 
marks both a structural and functional divide between GCs and internal theca cells 
[Amsterdam et al., 1975]. Coll IV affects the morphology of the parietal GCs, but also 
influences metabolic processes and binds several growth factors [McArthur et al., 
2000]. It has indeed been demonstrated that the ECM of the ovary is composed of a 
variety of molecules such as collagens type I and type IV, laminin and fibronectin 
[Hynes, 1992; Berkholtz et al., 2006; Irving-Rodgers et al., 2006] and that these are 
involved in a multitude of functional processes, including steroidogenesis and 
luteinization [Ben-Ze’ev et al., 1986; Yamada et al., 1999; Wang et al., 2000]. 
Cellular shape is influenced by various components of the ECM and differences in 
cell shape in turn influence important cellular processes such as metabolism, 
attachment and migration of cells [Folkman et al., 1978].   
4.2.4 THREE-DIMENSIONAL CULTURE 
In addition to the specific effects of the various components of the ECM, the latter 
allows the cells to grow in a 3D-environment, which has been shown to be essential 
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for sustaining the morphology of ovarian follicles, including cell–cell and cell–matrix 
interactions [Kreeger et al., 2003; Gomes et al., 1999], thereby promoting follicular 
growth and cell proliferation. In a 2D culture system, murine follicles fail to maintain 
their in vivo-like architecture [Cortvrindt et al., 1996; Berkholtz et al., 2006; West et 
al., 2007] and typically fail to grow [Abir et al., 2001]. The short-term beneficial 
effects of culturing GC in a 3D environment have been demonstrated previously 
[Carnegie et al., 1988; Wang et al., 2000], but not the long-term effects. As it has now 
become possible to culture human GC over prolonged time periods in the presence of 
LIF [Kossowska-Tomaszczuk et al., 2009], we conceived a set of experiments, to 
demonstrate that a significant subpopulation of human luteinizing GCs collected from 
mature ovarian follicles are able to maintain their functional characteristics over 
prolonged time period, when they are cultured in a 3D-matrix made of collagen type I, 
and that they can become integrated into newly developing follicles after GC 
transplantation into the ovaries of immuno-incompetent mice. 
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4.3 MATERIAL AND METHODS 
4.3.1 COLLECTION OF LUTEINIZING GC 
Luteinizing GCs were collected by transvaginal ultrasound-guided aspiration from 
infertile patients treated with controlled ovarian hyperstimulation for IVF or 
intracytoplasmic sperm injection (ICSI). For this purpose patients were treated with 
various gonadotropin preparations including either human menopausal gonadotropins 
(HMG, Menopur, Ferring, Switzerland; or Merional, IBSA, Switzerland) or 
recombinant FSH (Gonal F, Merck-Serono, Switzerland, or Puregon, Organon, 
Switzerland) followed by 10.000 IU of human chorionic gonadotrophin (HCG, 
Pregnyl, Organon). After removal of the cumulus oophorus-oocyte complexes (COC), 
the freshly collected follicular aspirates were centrifuged for 5 min at 800 rpm. GCs 
were separated from other cells by density gradient centrifugation on Ficoll PLUS 
(Amersham Bioscences, Sweden) for 20 min, 1500 rpm. Cells in the interphase layer, 
isolated by pipetting, were washed twice with Dulbecco’s modified Eagle’s (DMEM) 
culture medium and centrifuged again at 800 rpm for 5 min for final collection of the 
cells [Zhang et al., 2000]. The purified cells were placed in freezing medium (FCS 
with 10 % (v/v) dimethylsulphoxide (DMSO) and stored at –80 ºC until culture. All 
experiments outlined above were presented to and approved by the Ethics Committee 
of Basel, Switzerland, and patients signed an informed consent.  
4.3.2 CELL CULTURE 
All the experiments were performed in triplicate with pooled cells from different 
patients in order to reduce inter-individual differences between single patients. Using 
DMEM-high glucose (4500 mg/L glucose, Gibco, Switzerland), 15 % (v/v) fetal calf 
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serum (FCS, Gibco) human GCs were cultured either as monolayers or in 3D. The 
culture medium was also supplemented with penicillin/streptomycin (50 μg/ml), L-
glutamine (3 mmol/l), β-mercaptoethanol (10 mM stock solution in DMEM), 
recombinant human FSH (100 ng/ml or 3 x 10-4 IU/ml, Gonal F; Serono), 
recombinant human LH (200 ng/ml, Luveris, Serono) and 1000 IU/ml of the 
leukaemia-inhibing factor (LIF, Chemicon International, USA). For the 3D cell 
culture, approximately 3.5x105 GCs were mixed with 2,5 mg/ml type I collagen of rat 
origin (BD Biosciences), incubated for 15 min in 37 °C, and later centrifuged for 3 
min, at 1200 rpm, to form 3D pellets. Pellets were then cultured in conical microtubes 
(Sarstedt) set on an orbital shaker. 
4.3.3 CLONOGENIC CULTURES OF GCS AND FLUORESCENCE-ACTIVATED CELL 
SORTING  
GCs were identified and sorted by the presence of FSHR (Santa-Cruz Biotechnology) 
[Kossowska-Tomaszczuk et al., 2009] with FACSCalibur (Becton Dickinson). Single 
FSHR-bearing GCs were placed separately one by one in the wells of a 96-well plate. 
After one week of culture, small cellular clones were observed using an inverted 
microscope. At day 17, alkaline phosphates (AP) staining was performed, following 
the instructions provided by the manufacturer, (AP kit, Sigma-Aldrich).  
4.3.4 RT-PCR 
Total RNA was extracted from pooled GCs using RNeasy Total RNA kit from Qiagen 
(Germany). The quantity of RNA was measured by optical density at A260 nm (ND-
1000 Spectrophotometer, NanoDrop Technologies, USA). Total RNA (1 μg) was 
reverse transcribed into single strand cDNA using the cDNA synthesis kit 
(Boehringer Mannheim, Mannheim, Germany). Primers were synthesized by 
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Microsynth, Switzerland: FSHR F (forward) 5’TGGGCTGGATTTTTGCTTTTG, R 
(reversed) 5’CCTTGGATGGGTGTTGTGGAC (annealing temperature 55 °C, DNA 
product size 529 bp); Aromatase F5’CAAGTGGCTGAGGCAT, 
R5’GAGAATAGTCGGTGAA (55 °C, 429 bp). The cDNA amplification primers for 
OCT-4, FSHR and the LIF-receptor (LIFR) were designed to span introns to avoid 
genomic DNA contamination. The β-actin PCR product was used as internal control 
(Rapid Scan). The single strand cDNA was subjected to 35 cycles of PCR 
amplification using one of the primers sets. The amplified products were separated on 
1 or 2 % agarose gels. The RT-PCR products were analyzed by DNA sequencing 
(ABI, PE Applied Biosystems, USA). 
4.3.5 IMMUNOHISTOCHEMISTRY AND IMMUNOHISTOFLUORESCENCE 
To evaluate the characteristics of GCs after prolonged culture, the pellets were 
harvested for histological examination and gene expression analyses. For histological 
examination pellets were fixed overnight in 1 % paraformaldehyde at 4 °C, paraffin-
embedded and sectioned in 7 μm thick slices. Sections were stained with 
haematoxylin/eosin (H&E) and observed microscopically. For the demonstration of 
FSHR, LHR, Coll IV, 3β-HSD and Ki-67 either immunohistochemistry or 
immunohistofluorescence were performed using antibodies against human FSHR 
(Santa-Cruz Biotechnology), against human LHR (Santa-Cruz Biotechnology), 
against human Coll IV (DAKO, Denmark A/S), against 3β-HSD (Santa-Cruz 
Biotechnology) and against Ki-67 (Abcam), following the instructions provided by 
each manufacturer. Secondary antibody against FSHR were donkey anti-goat FITC 
(Santa-Cruz Biotechnology) or rabbit anti-goat biotin-conjugated (DAKO, Denmark 
A/S) antibodies. For LHR anti-rabbit mouse PE (Santa-Cruz Biotechnology) 
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secondary antibodies were used and for Coll IV goat anti-mouse biotin-conjugated 
(DAKO, Denmark A/S) secondary antibodies were used. Staining for 
immunohistochemistry were followed by incubation with ABC-alkaline phosphatase 
complex kit (Dako, Glostrup, Denmark), counterstained with hematoxylin and 
mounted. Some sections were also stained with Alcian Blue to identify Call Exner–
like bodies [van Wezel et al., 1999]. 
4.3.6 IMMUNOASSAY FOR IN VITRO DETERMINATION OF ESTRADIOL AND 
PROGESTERONE 
Secretion of estradiol and progesterone by GCs was measured in the culture 
supernatants by using the Elecsys Estradiol II and Progesterone II assays (Roche 
Diagnostics). The experiment was repeated four times. The results were presented 
either in pmol/L, for real values, for estradiol and progesterone. For calculation 
purpose the conversion factors were given (Roche Diagnostics):  
pmol/L x 0.273 = pg/mL (ng/L) or nmol/L x 0.314 = ng/mL (μg/L) 
pg/mL x 3.67 = pmol/L or ng/mL x 3.18 = nmol/L 
4.3.7 TRANSPLANTATION OF GCS INTO THE OVARIES OF IMMUNE-INCOMPETENT 
MICE  
The in vivo transplantation of cultured cells into the mouse ovary has never been 
successfully performed before, though some attempts were presented [Honda et al., 
2007]. The oocyte nursing functionality of human GCs cultured over prolonged time 
periods in 3D in the presence of LIF was assessed after transplantation into the 
ovaries of immuno-incompetent mice (e.g. nude mice). For that purpose GCs were 
first cultured in vitro for three weeks under the 3D conditions described above. The 
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pellets were then transplanted unilaterally into the right ovary of 8 nude mice (Harlan, 
NL) in accordance with institutional guidelines. The cells were transplanted under the 
bursa within the capsula of the mouse ovary. GC transplantation was always 
performed in the right ovary, the left one remained unoperated. Four to five weeks 
after implantation, the mice were sacrificed, the constructs harvested, fixed overnight 
in 1 % paraformaldehyde, paraffin-embedded and sectioned. Sections were then 
stained with H&E. To distinguish human (donor) from murine (recipient) cells, 
immunohistofluorescence was carried out with anti-human monoclonal HLA-ABC-
biotin-conjugated antibodies (Cedarlane Laboratories Ltd) with avidin-FITC 
secondary antibodies from Becton Dickinson. Additionally, chromogenic in situ 
hybridization (CISH, Zytovision kit) for the detection of Alu sequences was carried 
out. The Alu family consists of repetitive elements of DNA, characteristic of primate 
genomes [Roy-Engel et al., 2001].  
4.3.8 ASSESSMENT OF GC’S PHENOTYPE AFTER ECTOPIC TRANSPLANTATION INTO 
IMMUNE-INCOMPETENT MICE 
As no specific anti-human FSHR antibodies were found, that could be used to 
differentiate human from mouse GCs, the continued presence of the GC phenotype 
after prolonged cultured in 3D was evaluated through ectopic, extra-ovarian 
transplantation in immuno-incompetent mice. For that purpose, GCs were first 
cultured in vitro for three weeks under 3D conditions as described above. Pellets 
containing the GC were then transplanted into the back of nude mice (CD-1 nu/nu, 1-
month old; Charles River Laboratories, Wilmington, MA, http://www.criver.com) in 
accordance with institutional guidelines. Four and eight weeks after implantation, the 
mice were sacrificed, the constructs harvested and fixed overnight in 1 % 
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paraformaldehyde, paraffin-embedded and sectioned. Sections were then stained with 
H&E or with antibodies against FSHR. 
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4.4 RESULTS  
4.4.1 CULTURE IN MONOLAYER 
When selected out off a large cohort of GCs based on the FSHR and culture as a 
single cell in one singe well, GCs were able to undergo clonogenic growth resulting in 
multicellular colonies (Figure 1A) staining for AP (Figure 1B). When GCs were 
cultured as monolayers (2D), cells adhered to the bottom of the well, spreaded and 
adopted a fibroblast-like shape (Figure 1C) while loosing characteristics typical of 
GCs. Indeed, the expression of the FSHR became undetectable after 17 days in 
culture in 2D (Figure 1D). However, when GCs were cultured as 3D pellets  together 
with type I collagen, they maintained their round-spherical shape with clumping of 
cells (Figure 1E) and the FSHR remained expressed (Figure 1D). Cytochrome P450 
aromatase was expressed in both culture systems (Figure 1D). The presence of FSHR 
in GCs cultured in 3D with collagen type I was also demonstrated at the protein level 
after 21 days, as visualized by immunocytochemistry using an anti-FSHR polyclonal 
antibody (Figure 2 and 3). 
4.4.2 THREE-DIMENSIONAL CULTURE 
In the 3D pellets patches of GCs were stained with FSHR, suggestive of the spatial 
organization of granulosa relative to the basal membrane, similar as in ovarian antral 
follicles (Figure 2G). In order to further substantiate this, the organized structures 
were stained with antibodies against Coll IV (Figure 2H), a typical marker of the 
basal membrane in mature ovarian follicles [Timpl et al., 1986; Rodgers et al. 1999]. 
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Figure 1. Clonogenic proliferation of GC collected from mature ovarian follicles of 
infertile women treated with assisted reproductive technology. (A) Clonogenic 
proliferation of one single GC cultured for 12 days in a single well in LIF 
supplemented medium. (B) Staining of clones of GCs for AP. (C) Flattened 
appearance of GCs during prolonged culture in 2D in the presence of collagen type I. 
(D) RT-PCR of various markers typical for GC function, FSHR and P450-aromatase, 
in freshly collected GC (fGC), after short (3 days) and prolonged (17 days) culture in 
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the presence of collagen type I in either 2D or 3D. RT +/- signifies RT-PCR control. 
M signifies DNA marker. (E) Rounded appearance of GCs cultured in 3D in the 
presence of collagen type I. 
Expression and organization of FSHR-expressing cells and collagen type IV in 3D 
pellets were analyzed by immunocytochemistry (Figure 2). After two days of culture, 
Coll IV was expressed by GCs randomly distributed throughout the pellet. At day 7, 
spherical structures composed of several GCs were observed. At day 21, organized 
structures of GCs expressing FSHR and containing laminar structures with collagen 
type IV were visible, some of which of large scale (several hundreds of micrometers), 
suggestive of the organization of a genuine ovarian follicle [Irving-Rodgers 2005]. 
Collagen type IV was more expressed in the outer layers of the organized structures, 
whereas staining for FSHR-positive GCs, was mostly visible in the inner part of the 
structures (Figure 2G, 2H). The number of GCs patches in the 3D pellets significantly 
increased with time (Figure 3A, 3B, 3C). 
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Figure 2. Immunocytochemistry for FSHR (A,B,C) and collagen type IV (D,E,F) in 
GCs cultured in 3D together with collagen type I during various time intervals. (G,H) 
Patches of GCs cultured in the presence of collagen type I, as stained with 
immunocytochemistry for the FSHR (G) and Coll IV (H). Cells with the FSHR are 
more abundant in the center of each patch, whereas Coll IV is more abundant in cells 
at the periphery of each patch. 
4.4.3 PRESENCE OF FSH AND LH RECEPTORS 
Using immunocytofluorescence, we also demonstrated the presence of LHR in 
patches of GCs growing in 3D (Figure 3). The expression of LHR required 
concomitant expression of FSHR. We encountered two distinct staining patterns of 
LHR and FSHR. The first group was negative for LHR but positive for FSHR (Figure 
3D, 3E, 3F). The second group was positive for both LHR and FSHR (Figure 3G, 3H 
and 3I). We were not able to precisely quantify the proportion of cells with the FSHR 
alone and those with both receptors within the 3D-pellets, because the patches had 
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different sizes and because it was not possible to distinguish single cells inside the 
patches with a sufficient degree of accuracy. All negative controls, performed without 
first antibodies, presented minimal background staining (data not shown).  
 
 
Figure 3. FSHR-immunocytochemistry in GCs cultured in 3D together with collagen 
type I after 1 week (A) and after 3 weeks (B). (C) The number of patches positive for 
FSHR was counted after one week (grey column) and after three weeks (black 
column) in culture. Both FSHR (D,E.F) and LHR (G,H,I) were visualized with 
immunocytofluorescence in GC after three weeks in 3D culture in the presence of 
collagen type I. 
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4.4.4 PROLIFERATION STATUS 
Moreover, when observing the 3D pellets at higher magnification, spherical clumps of 
GCs surrounding a central cavity which recall a rosette-like structure, became visible 
within the patches stained for FSHR (Figure 4A-E). The connective tissue 
surrounding these rosettes contained Coll IV, whereas their central cavity was stained 
by Alcian Blue, exhibiting a staining pattern typical of Call-Exner bodies which are 
also present in ovarian follicles [van Wezel et al., 1999]. The proliferation status of 
GC, another marker of GC functionality [Bullwinkel et al., 2006], was verified using 
Ki-67 staining (Figure 4E). Around half of the cells in the follicle-like structures were 
positive for Ki-67. Few cells staining for Ki-67 were also found outside the patches of 
cells staining for FSHR, but most were found in their close vicinity. 
4.4.5 ENDOCRINE FUNCTION 
The endocrine function, characterized by the steroidogenic capacity of GCs cultured 
in 3D was also examined. The concentrations of progesterone and estradiol were 
measured in the supernatant medium after various time intervals (Figure 5A and 5B). 
These measurements were performed in 4 independent experiments. When compared 
to GCs cultured in 3D in the presence of collagen type I, significantly lower 
concentrations of progesterone were measured in the supernatant medium of GCs 
cultured in 3D together with collagen type (p<0.01), whereas the concentrations of 
estradiol were similar. In addition to aromatase, characteristic of GC function, the 
presence of another steroidogenic enzyme, namely 3β-HSD, was tested by 
immunohistochemistry (Figure 5C). Most of the cells positively staining for 3β-HSD 
were found inside the patches of cells staining for FSHR. 
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Figure 4. GCs cultured in 3D in the presence of collagen type I progressively form 
follicle-like structures, which also include rosette-like structures similar to Call-Exner 
bodies, as stained with Coll IV (A,B, grey arrows), Alcian blue (E, black arrows) and 
also containing cells with FSHR (C,D, green arrows). (F) Proliferation of GCs 
cultured in 3D in the presence of collagen type I was demonstrated with Ki-67 
stainings. GCs marked with Ki-67 staining are arranged in patches of cells 
reminiscent of ovarian follicles (F, black arrows). 
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Figure 5. The concentrations of estradiol and progesterone were measured in the 
supernatant medium of GCs cultured in 3D either together with collagen type I or 
without collagen type I after various time periods in culture. Whereas at all time 
points the concentrations of estradiol were not significantly different among both 
groups, the concentrations of progesterone were significantly lower at various time 
points (P<0.01, Mann Whitney-U test), indicating a lesser degree of spontaneous 
luteinization in the presence of collagen type I. The asterisks indicate lacking values, 
which were caused by the disintegration of the pellets after three weeks in culture in 
the absence of collagen type I. The presence of the key steroidogenic enzyme 3β-HSD 
involved in the production of progesterone was demonstrated with 
immunocytochemistry in patches of GCs forming follicle-like structures. 
4.4.6 FOLLICLE GROWTH  
Additional proof of the 3D-system’s utility and relevance arose from its ability to 
promote the development of early-stage antral follicles (Figure 6A and B). Previous 
anecdotal observational studies have demonstrated that follicular aspirates of infertile 
patients treated with IVF or ICSI may contain primordial follicles, usually not 
identified during routine workup of the aspirates for oocyte collection [Heng et al., 
2005]. Accidentally, three primary ovarian with multiple layers of GCs, each with an 
enclosed oocyte, were occasionally detected in the 3D-pellets after approximately 14 
days of culture (Figure 6C).  
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Figure 6. (A and B) Multilayered follicles founded within 3D cultured GC after more 
than 2 weeks (OO – oocyte; GC – granulosa cells). (C) Post-matured oocyte founded 
within 3D cultured GC after more than 3 weeks (black arrow – first polar body; red 
arrow – zone pellucida; white arrow - cytoplasm). 
4.4.7 TRANSPLANTATION OF HUMAN GRANULOSA CELLS 
In order to further examine their functionality 3D-pellets with human GCs were 
transplanted in the ovaries of eight immuno-incompetent mice. Four mice were 
sacrificed 4 weeks after transplantation, whereas another four mice were sacrificed 
after 8 weeks. In each animal the contralateral, non-operated ovary was used as a 
control. To evaluate possible differences between operated and non-operated ovaries, 
H&E staining of whole ovaries was performed (Figure 7A and B). The presence of 
human cells within ovarian tissue was then established using two specific stainings: 
CISH for Alu sequences (Figure 7C) and immunohistofluorescence for HLA-ABC 
(Figure 7D). With both methods the presence of cells of human origin was confirmed 
almost exclusively within the boundaries of mouse antral follicles. 
4.4.8 MAINTENANCE OF FSHR IN VIVO 
In order to demonstrate the maintenance of human GC phenotype after in vivo 
transplantation, cultured GC pellets were implanted into the back (ectopically) of 
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nude mice. After 4 and after 8 weeks of implantation, the FSHR was still found to be 
present within the explanted tissue (Figure 7E and F), as observed both by 
immunohistochemistry and immunohistofluorescence. 
 
Figure 7. GCs cultured for three weeks in 3D in the presence of collagen type I were 
transplanted into the right ovaries of immunoincompetent mice. The contralateral 
ovary was left unoperated for control purposes. The animals were sacrified 4 or 8 
weeks after transplantation. (A,B) no differences were found in gross morphology 
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between the operated and the non-operated ovaries. (C) with alu sequences and (D) 
with HLA-ABC staining human cells were mostly detected within the boundaries of 
mouse follicles. After transplantation in the back of immunoincompetent mice FSHR-
bearing cells were still present eight weeks later, as visualized with 
immunocytochemistry (E, red arrows) or with immunocytofluorescence (F, green 
dots).  
  
- 96 - 
4.5 DISCUSSION  
4.5.1 PREVIOUS STUDIES 
Within few days in culture, rat, ovine and human GCs plated on culture dishes 
invariably undergo spontaneous luteinization followed by apoptosis within few days 
[Aharoni et al., 1997; Hwang et al., 2000; Huet et al., 2001]. Previous research in our 
laboratory has demonstrated that among GCs collected from infertile women treated 
with assisted reproduction a subpopulation with multipotent stem cells can be 
identified, which can be cultured over prolonged time periods in vitro in the presence 
of LIF [Kossowska-Tomaszczuk et al., 2009]. In the present communication, these 
findings are supported by the clonogenic growth of single GCs to 3D colonies, 
staining positively for AP, when they are cultured in the presence of LIF. However, 
although in the presence of LIF some GCs could be maintained in culture, they 
progressively lost all their major characteristics, such as P450-aromatase and FSHR 
[Kossowska-Tomaszczuk et al., 2009]. 
4.5.2 THREE-DIMENSIONAL CULTURE 
As the beneficial role of 3D-cultures on the endocrine properties of cells was already 
documented in previous studies [Carnegie et al., 1988; Gomes et al., 1999; Berkholtz 
et al., 2006; Aten et al., 1995; Vigo et al., 2005], we decided to improve our culture 
system by incubating GCs in 3D together with LIF instead of monolayers. Alginate 
hydrogels, a widely used substitute of the ECM in tissue engineering and 
characterized by optimal biomechanical properties, have been used to promote  the 
development of mouse ovarian follicles in vitro and both oocyte maturation and life 
offspring has already been achieved with this method [Xu et al., 2007; West et al., 
2007]. However, alginate hydrogels are manufactured from brown algae and consist 
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of a polymeric scaffold of polysaccharides, therefore, being unphysiological for 
human ovarian tissue. An alternative solution was offered by collagen type I, which is 
a normal constituent of ovarian tissue. We therefore evaluated the effectiveness of a 
3D-culture system based on collagen type I in a medium supplemented with LIF on 
the maintenance of the properties of GCs during prolonged culture. Initially, control 
GCs were cultured as 3D-pellets without collagen type I. Unfortunately, under those 
conditions the pellets progressively disaggregated within 1 to 2 weeks. Therefore, 
GCs cultured as monolayers in the absence of collagen type I were used as controls.  
4.5.3 GRANULOSA CELLS PHENOTYPE 
The 3D-culture system of GCs coated with collagen type I not only extended cellular 
survival in vitro but also allowed the GCs to maintain many of their morphological 
and functional characteristics. Aggregated, 3D-cultured GCs retained key features 
such as FSHR, LHR and P450-aromatase, which otherwise progressively disappeared 
during culture as monolayers. The demonstration of both FSHR and Coll IV in GCs 
cultured in 3D over a period of 3 weeks was highly reproducible and suggests that this 
culture system mimics physiological ovarian follicular development. Similar 
experiences were made earlier when whole ovarian follicles were cultured in vitro 
[Ben-Ze’ev et al., 1986; Ben-Rafael et al., 1988; Amsterdam et al., 1989; Mauchamp 
et al., 1998; Richardson et al., 2000; Berkholtz et al., 2006]. In a 3D-culture system 
with intact murine follicles collagen type I promoted an increase in size of two-
layered follicles but had no effect on multilayered follicles [Berkholtz et al., 2006]. 
Collagen type I and collagen type IV have been shown to stimulate the formation of 
preantral follicles. In the 3D model presented here, Coll IV was found to surround 
patches of GCs containing the FSHR. This is in accordance with the observation that 
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in early antral follicles Coll IV is localized specifically in the basal membrane 
[Amsterdam et al., 1975], whereas in pre-ovulatory follicles Coll IV is also detected 
in more central layers of the granulosa [Yamada et al., 1999]. The basal membrane 
influences GC proliferation and differentiation [Andersen et al., 1976; Amsterdam et 
al., 1989; van Wezel et al., 1998; Richardson et al., 1992; Luck, 1994] and our 
observation confirms previous results [Irving-Rodgers et al., 2006] by demonstrating 
that Coll IV, a major component of the basal membrane and of the ECM, is produced 
by the GCs themselves. 
4.5.4 EXTRA-CELLULAR MATRIX 
Collagen fibers are the most abundant protein constituents of the ECM and various 
subtypes of collagens have been demonstrated in both the animal and human ovary 
[Hynes, 1992; Irving-Rodgers et al., 2005; Berkholtz et al., 2006; Irving-Rodgers et 
al., 2006]. There are approximately 28 types, that have been described, but the first 
four types are the most common: 
Collagen type I the most abundant collagen type, present in scar tissue 
Collagen type II the main component of cartilage 
Collagen type III component of early granulation, produced by fibroblasts 
Collagen type IV main component of the basal membrane. 
Collagens have been demonstrated to be in various compartments of the ovary of 
many species, such as the rat and the human. Whereas collagen type IV has been 
shown to be present in the basal membrane, separating the theca interna and the 
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granulosa, collagen type I and type III are present in the theca externa and type I in 
the granulosa cell layer [Lind et al., 2006]. Together with laminin, another important 
component of the basal membrane, collagen interacts with its neighbouring granulosa 
cells via integrins expressed on the membrane of GCs [Le Bellego et al., 2002; West 
et al., 2007]. 
4.5.5 PRESENCE OF FSH AND LH RECEPTORS 
During follicular development in vivo, the FSHR density rises progressively until a 
few days before ovulation, whereas the LHR becomes expressed only towards the 
final stages of follicular development. Therefore, expression of LHR is thought to be 
a hallmark of the later stages of GC differentiation [O’Shaughnessy et al., 1997]. We 
demonstrated both at the mRNA level and at the protein level the presence of the 
LHR in a subset of GCs cultured in 3D but not in 2D. 
4.5.6 PROLIFERATION STATUS 
The granulosa of ovarian preantral and antral follicles in many species including the 
human contains Call–Exner bodies. Call-Exner bodies consist of round globular sets 
of granulosa cells (called rosette), containing chains of Coll IV [Rodgers et al., 1998], 
surrounding a small cavity with a fluid, reminiscent of follicular fluid. Call-Exner 
bodies are found only in healthy follicles [Rodgers et al., 1999; Van Wezel et al., 
1999] and their presence seems to correlate to GC’s proliferation and differentiation 
[Assoian, 1997; Correia et al., 1998; Lee et al., 1996]. Call-Exner bodies can be 
demonstrated in follicular sections either with Alcian Blue staining or with specific 
antibodies against collagen IV [van Wezel et al., 1999]. Using these two methods 
structures similar to Call-Exner bodies were observed within patches of GCs, cultured 
in 3D but not in 2D. The presence of Call-Exner bodies in ovarian follicles has been 
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used as an index of granulosa cell proliferation [Miller et al., 1997; Gomes et al., 
1999]. Using Ki-67 [Bullwinkel et al., 2006; Schonk et al., 1989] we were able to 
demonstrate that cell proliferation occurs in 3D-cultured GCs [Scholzen et al., 2000]. 
Interestingly, during prolonged culture most proliferating cells progressively became 
organized in structures reminiscent of ovarian follicles with cells staining for the 
FSHR and the LHR and surrounded by Coll IV [Rodgers et al., 1999; Rodgers et al., 
2001; Vigo et al., 2005; Gomez et al., 1999]. 
4.5.7 ENDOCRINE FUNCTION 
Steroidogenesis was then evaluated as another important feature of GCs. In all 
experiments both recombinant FSH and LH were supplemented to the culture 
medium, in order to maintain and stimulate steroidogenesis. Through the presence of 
the cytochrome P450-aromatase, intact GCs are able to produce significant amounts 
of estradiol [Okamura et al., 2003], which, among other characteristics, reflects their 
functional health [Rodgers et al., 2001]. The concentrations of estradiol were similar 
in the supernatant medium of GCs cultured in 3D in the presence of collagen type I as 
compared to GCs cultured as pellets without collagen type I (Figure 5). In contrast, 
the concentration of progesterone was significantly lower in the supernatant of GCs 
cultured in 3D together with collagen type I when compared to GCs cultured in pellets 
without collagen type I (p<0.01), suggesting that spontaneous luteinization is less 
pronounced in the presence of collagen type I. In addition to the secretion of 
progesterone and estradiol and to the P450-aromatase expression, the presence of the 
3β-HSD, a key enzyme in steroidogenesis, involved primarily in the synthesis of 
progesterone, was observed in 3D-grown GCs as well, [Frindik, 2008; Fanjul et 
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al.,1984] and only functional GC are able to express this enzyme. [Wang et al., 1995; 
Richards, 1994]. 
4.5.8 FOLLICLE GROWTH 
Follicular aspirates are potentially an abundant source of immature ovarian follicles 
[Wu et al., 1998]. Attempts to culture primordial follicles in vitro, to increase the 
yield of viable mature oocytes for fertility treatments have not yet met with success 
[Heng et al., 2005]. Taking all these findings together, we suggest that this newly 
described 3D culture system based on collagen type I and LIF display a development 
which is reminiscent to surrogate follicle-like structures. It remains to be 
demonstrated, whether these can be further developed to sustain the growth and the 
maturation of oocytes. 
4.5.9 GRANULOSA CELLS FUNCTIONALITY 
In order to further establish the robustness of functionality of GCs after prolonged 
3D-culture in the presence of collagen type I, human GCs were transplanted into the 
ovaries of immunoincompetent mice. The human GCs were differentiated from the 
surrounding mouse ovarian tissue both with HLA-ABC-immunostaining and with 
primate-specific Alu sequences [Roy-Engel et al., 2001]. Human GCs were found to 
be located predominantly within the boundaries of mouse follicles and to a much 
lesser extent between individual mouse follicles [Hatano et al., 1999]. The human 
cells were grouped in patches suggestive of localized proliferation. Transplanted cells 
migrated towards the center of follicles and were also found in close proximity of 
mouse oocytes, where they retained the typical epithelial morphology of GCs 
surrounding an oocyte. As no specific anti-human FSHR-antibody was available to 
differentiate human FSHR from mouse FSHR, pellets with 3D-cultured GCs were 
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also transplanted ectopically into the back of immunoincompetent mice. With this 
approach we additionally demonstrated the continuing expression of FSHR in GCs 
coated with collagen type I up to 8 weeks after their transplantation into this 
environment. 
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4.6 CONCLUSIONS 
Taking all these findings together, we have demonstrated that subpopulations of GCs 
collected from mature ovarian follicles can be cultured over prolonged time periods in 
a 3D-system consisting of collagen type I and that under those conditions these cells 
are able to proliferate into organized patches of cells, reminiscent of ovarian follicles. 
In female mammals, physiological production of oocytes with high developmental 
competence crucially relies upon the controlled growth and differentiation of the GCs 
in the surrounding ovarian follicle. For decades, the inability to culture these GCs 
over prolonged time periods has greatly contributed to the current lack of knowledge 
about their functionality. It is now possible to culture human GCs, otherwise thought 
to enter apoptosis within days after their removal from the follicle, over prolonged 
time periods thereby retaining many aspects of their function. Although maintenance 
of human oocytes in the presence of 3D-cultured GCs has not yet been performed, the 
present data provide the basic system which may now be further developed for the 
maturation in vitro of oocytes both in human and animal reproductive medicine. The 
possibility for long-term culture of subpopulations of GCs is likely to have 
considerable impact on various aspects of research into ovarian physiology, high 
throughput screening of new medications targeting ovarian function and ovarian 
endometriosis. 
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5 DISCUSSION AND CONCLUSIONS 
5.1 SOMATIC STEM CELLS IN THE OVARY 
In contrast to the ongoing controversy with regard to the possibility of ongoing 
renewal of oogenesis in the ovary and the possible existence of adult germ stem cells, 
the existence of somatic stem cells in the ovary has not been hypothesized for a long 
time.  
Granulosa cells (GCs) cultured in vitro invariably cease to proliferate already after 
two to three passages. Similar results have been obtained when culturing thecal cells. 
Recently, it has been shown that the four growth factors, bFGF, EGF, LIF, and IGF1 
exhibited significant enhancing effects on colony growth of thecal cells, leading to the 
detection of stem cells in the thecal layer of the ovary [Honda et al., 2007]. 
In vivo, the follicular basal membrane leads to the entrapment in the follicular fluid 
containing large molecules (e.g., growth factors) synthesized both by granulosa cells 
and oocytes. The molecular mass cut-off of the follicular barrier is calculated to be 
100 to 500 kd [Shalgi et al., 1973]. The basal membrane may also restrict the 
diffusion of growth factors into the blood circulation. This isolating property of the 
basal membrane surrounding the follicle allows it, in part, to determine the micro-
environment, in which granulosa cells and the oocyte may thrive [Irving-Rodgers et 
al., 2006].  
Growth factors - such as LIF - may be one of those factors influencing estradiol 
biosynthesis in the ovarian follicle. It has been demonstrated previously that LIF is 
involved in ovulation, as the concentration of LIF in the follicular fluid has been 
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shown to rise steadily after the LH surge or after administration of HCG [Arici et al., 
1995; Coskun et al., 1998]. 
Functional properties of stem cells in general include pluripotency, mitosis without 
differentiation, when confined to their niche, and by their ability to proliferate when 
isolated out off their niche [Potten et al., 1990]. The extracellular matrix is crucial for 
maintaining the pluripotency of stem cells through contact inhibition. Lack of contact 
inhibition occurs in vivo during growth of a follicle [Rodgers et al., 1995a] 
particularly during the preantral stage of follicular development, when granulosa cells 
are in close physical contact to the extracellular matrix. [Rodgers et al., 2001]. 
The hypothesis for the presence of stem cells in the granulosa was first postulated, 
when it was demonstrated that the granulosa possesses some marked similarities to 
other epithelia in the body [Rodgers et al., 1999; van Wezel et al., 1998]. The 
granulosa of ovarian follicles resides on a basal membrane and the morphology of the 
cells highly differs in various regions of the granulosa. These authors concluded that 
there must be populations among the granulose cells containing less differentiated 
cells and, at a distance from these, populations with highly differentiated cells (Figure 
1).  
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Figure. 1. A model of replication and differentiation of the granulosa and cumulus 
cells that occurs during follicular development. The model encompasses stem cells, 
transit amplifying cells (replicating:specializing), and differentiating cells. It thus 
allows for different factors, such as matrix, cellular contacts or growth factors, to act 
separately on each lineage and at each stage of development [Rodgers et al., 1999] 
Additional support for the presence of cells with stem cell characteristics in the 
granulosa was provided by nuclear transfer from somatic cells to oocytes in cloning, 
particularly in cattle [Wells et al., 1999]. It is known that embryonic development via 
nuclear transfer is more successful, when the donor nucleus is taken from a less 
differentiated cell, i.e. granulosa. The high success of cloning using the nuclei of 
granulosa cells in cattle may well be due to the stem cell character of some of the 
granulosa cells [Rodgers et al., 2001]. 
Additional evidence for the existence of stem cells in granulosa comes from their 
ability to express telomerase. Telomerase activity is inactive in normal somatic cells 
[Chiu et al., 1997] and the length of the telomere-repeat sequence decreases during 
every cell division. In contrast, telomerase activity is more expressed in tissues with 
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high numbers of stem cells [Kim et al., 1994; Wright et al., 1996]. In the ovary, the 
telomerase-RNA was found in the granulosa of growing follicles, but not in 
primordial follicles [Rodgers et al., 2001]. 
Another recent study in the Drosophila model [Kai et al., 2004] provided convincing 
evidence that somatic progenitors (nurse cells) of germ-line stem cells had the ability 
to revert back to the stem-cell stage. This introduces the possibility that within the 
mammalian ovarian follicle, similar somatic progenies of germ-line stem cells may 
also possess a greater intrinsic ability to revert back into functional stem cells. If this 
is the case, then a favoured candidate would be the cumulus/granulosa of ovarian 
follicles, since such cells are the homologues of nurse cells found within Drosophila 
ovary [Heng et al., 2005]. Hochedlinger and coworkers postulate that the epigenetic 
changes that direct terminal differentiation and permanent exit from the cell cycle are 
reversible [Hochedlinger et al., 2006]. 
The present thesis provides first line evidence for the presence of stem cells in the 
granulosa, as we observed that cells isolated from mature human ovarian follicles 
expressed the stem cell marker Oct-4. POU5F1 (Oct-4) is known to be expressed in a 
few cells found in the basal layer of human skin epidermis [Tai et al., 2005]. As GCs 
represent one of the most dynamic epithelia in the body, this could be as well true for 
GCs and explain its stable expression of Oct-4. 
As mentioned, most adult tissues contain a heterogeneous population of cells with a 
hierarchy of multipotent stem cells, progenitor cells and terminally differentiated 
cells. [Hochedlinger et al., 2006]. We hypothesized that within preovulatory follicle 
there are several subpopulations of GCs with distinct characteristics. GCs expressing 
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both FSHR and LHR, which we denominated luteinized GCs, will enter apoptosis 
during prolonged culture in vitro. GCs, positive for FSHR but not for LHR, may 
either become dedifferentiated to the progenitor GCs or differentiate to luteinized 
GCs (Figure 2). 
 
 
Figure 2. Hypothesis presenting several subpopulations of GCs within preovulatory 
follicle.  GCs stem cells: positive only for FSHR. Progenitor GCs: positive for both 
FSHR and moderately for LHR markers. Luteinized GCs: positive for FSHR and 
LHR markers.  
The study by Van Deerling and coworkers suggests that the cohort of granulosa cells 
in a human preovulatory follicle is derived from a clonal expansion of a small number 
(3 cells) of ovarian stem cells [Van Deerlin et al., 1997]. 
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The presence of a subpopulation of GCs with multipotent stem cell characteristics 
explains why GCs, taken from preovulatory follicles and cultured under the 
appropriate conditions, can survive over prolonged time periods, and can be 
differentiated into other tissue types, otherwise not present in the ovary. In addition, 
when cultured in 3D in an extracellular matrix similar to the ovary, the GCs seem to 
retain most of their characteristics including the FSHR and steroidogenesis.  
The unexpected finding of cells displaying multipotency and having a prolonged 
lifespan, extracted from mature ovarian follicles, is likely to have a significant impact 
on evolving theories in ovarian physiology, particularly with reference to the 
pathogenesis of ovarian endometriosis and ovarian cancer. Multipotent stem cells in 
ovarian follicles may be involved in the early origin of some forms of ovarian cancer 
as well as to the origin of ovarian endometriosis, which is considered to arise from 
undifferentiated, hitherto labeled as metaplastic cells in the ovary (Figure 3). 
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Figure 3. Discovery of the multipotent granulosa stem cells strengthen evolving 
theories in ovarian physiology [Okumara et al., 2003]. 
In female mammals, the normal and physiological production of good quality gametes 
relies upon the highly controlled growth and differentiation of the surrounding 
ovarian follicle. GC proliferation is maintained throughout folliculogenesis, providing 
not only a specialized micro-environment but also nutrients for oocytes growth. In 
vitro maturation (IVM) and in vitro fertilization (IVF) of oocytes is now an intriguing 
challenge in human and veterinary reproductive biotechnology. The discovery of GC 
multipotency and the use of granulosa stem cells in the newly-developed 3D in vitro 
culture system presented here may provide a promising technical tool for IVM but 
also for drug targeting purposes, as it provides an environment in which GCs preserve 
their functional properties. The reorganization of 3D-cultured granulosa stem cells 
into in vivo follicles could suggest as well the possibility of treatments against 
infertility by transplantation of 3D-expanded GCs which might be able to help to 
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construct healthy follicles. Such GCs transplantation into the ovary could as well 
restore the proper ovarian endocrine function in women suffering of premature 
ovarian failure or in women afflicting by a malignant disease, who can only be treated 
with chemotherapy leading to premature menopause. 
The outlook for the studies would be the co-culture of granulosa stem cells with 
oocytes. Those important studies would provide not only the information about oocyte 
nursing function, biology function, of GC in the newly-developed 3D in vitro culture 
system. But also open the opportunities for other new research as the biology and 
production of follicular fluid.  
5.2 GERM-LINE STEM CELLS IN THE OVARY 
For decades, scientists have thought that female mammals are born with a lifetime 
supply of oocytes in the ovary, irreversibly destined to decline after birth. However, in 
recent years a significant controversy with regard to the potential replenishing effects 
of cells from the bone marrow and blood on ovarian follicular renewal has been 
stirred up. Although these claims have been met with harsh skepticism, if they prove 
to be true, the current understanding of the female reproductive system must be 
revisited. Although these observations and allusions have been limited to the mouse 
system only, they have opened new discussions about the potential consequences of 
bone marrow transplantation and even blood donation to the replenishment of the 
female genital system in general. Still, these findings have not been replicated in other 
research laboratories so far and the proof that oogenesis can be renewed after birth 
from cells originating in the bone marrow is still lacking.  
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